{
    "id": "dbpedia_2269_3",
    "rank": 50,
    "data": {
        "url": "https://www.nature.com/articles/s41586-019-1907-7",
        "read_more_link": "",
        "language": "en",
        "title": "The evolutionary history of 2,658 cancers",
        "top_image": "https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41586-019-1907-7/MediaObjects/41586_2019_1907_Fig1_HTML.png",
        "meta_img": "https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41586-019-1907-7/MediaObjects/41586_2019_1907_Fig1_HTML.png",
        "images": [
            "https://pubads.g.doubleclick.net/gampad/ad?iu=/285/nature.com/article&sz=728x90&c=943253251&t=pos%3Dtop%26type%3Darticle%26artid%3Ds41586-019-1907-7%26doi%3D10.1038/s41586-019-1907-7%26techmeta%3D23,45%26subjmeta%3D114,181,631,67,69,692,699,735%26kwrd%3DCancer+genomics,Computational+biology+and+bioinformatics,Molecular+evolution",
            "https://media.springernature.com/full/nature-cms/uploads/product/nature/header-86f1267ea01eccd46b530284be10585e.svg",
            "https://media.springernature.com/w215h120/springer-static/image/art%3A10.1038%2Fs41467-023-41670-3/MediaObjects/41467_2023_41670_Fig1_HTML.png",
            "https://media.springernature.com/w215h120/springer-static/image/art%3A10.1038%2Fs41586-020-1969-6/MediaObjects/41586_2020_1969_Fig1_HTML.png",
            "https://media.springernature.com/w215h120/springer-static/image/art%3A10.1038%2Fs41586-020-1943-3/MediaObjects/41586_2020_1943_Fig1_HTML.png",
            "https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41586-019-1907-7/MediaObjects/41586_2019_1907_Fig1_HTML.png",
            "https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41586-019-1907-7/MediaObjects/41586_2019_1907_Fig2_HTML.png",
            "https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41586-019-1907-7/MediaObjects/41586_2019_1907_Fig3_HTML.png",
            "https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41586-019-1907-7/MediaObjects/41586_2019_1907_Fig4_HTML.png",
            "https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41586-019-1907-7/MediaObjects/41586_2019_1907_Fig5_HTML.png",
            "https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41586-019-1907-7/MediaObjects/41586_2019_1907_Fig6_HTML.png",
            "https://pubads.g.doubleclick.net/gampad/ad?iu=/285/nature.com/article&sz=300x250&c=389304833&t=pos%3Dright%26type%3Darticle%26artid%3Ds41586-019-1907-7%26doi%3D10.1038/s41586-019-1907-7%26techmeta%3D23,45%26subjmeta%3D114,181,631,67,69,692,699,735%26kwrd%3DCancer+genomics,Computational+biology+and+bioinformatics,Molecular+evolution",
            "https://www.nature.com/static/images/logos/sn-logo-white-ea63208b81.svg",
            "https://www.nature.com/static/images/logos/nature-briefing-logo-cancer-white-bc263e7d57.svg",
            "https://verify.nature.com/verify/nature.png",
            "https://www.nature.com/213v50u5/article/s41586-019-1907-7"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [
            "Paul T",
            "David C",
            "Van Loo",
            "Stefan C",
            "Thomas J",
            "Vázquez-García",
            "Dimitri G",
            "Paul C",
            "David D",
            "S. Cenk"
        ],
        "publish_date": "2020-02-05T00:00:00",
        "summary": "",
        "meta_description": "Cancer develops through a process of somatic evolution1,2. Sequencing data from a single biopsy represent a snapshot of this process that can reveal the timing of specific genomic aberrations and the changing influence of mutational processes3. Here, by whole-genome sequencing analysis of 2,658 cancers as part of the Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium&nbsp;of the&nbsp;International Cancer Genome Consortium (ICGC) and The Cancer Genome Atlas (TCGA)4, we reconstruct the life history and evolution of mutational processes and driver mutation sequences of 38 types of cancer. Early oncogenesis is characterized by mutations in a constrained set of driver genes, and specific copy number gains, such as trisomy 7 in glioblastoma and isochromosome 17q in medulloblastoma. The mutational spectrum changes significantly throughout tumour evolution in 40% of samples. A nearly fourfold diversification of driver genes and increased genomic instability are features of later stages. Copy number alterations often occur in mitotic crises, and lead to simultaneous gains of chromosomal segments. Timing analyses suggest that driver mutations often precede diagnosis by many years, if not decades. Together, these results determine the evolutionary trajectories of cancer, and highlight opportunities for early cancer detection. Whole-genome sequencing data for 2,778 cancer samples from 2,658 unique donors across 38 cancer types is used to reconstruct the evolutionary history of cancer, revealing that driver mutations can precede diagnosis by several years to decades.",
        "meta_lang": "en",
        "meta_favicon": "/static/images/favicons/nature/apple-touch-icon-f39cb19454.png",
        "meta_site_name": "Nature",
        "canonical_link": "https://www.nature.com/articles/s41586-019-1907-7",
        "text": "To systematically examine the mutational timing of chromosomal gains throughout the evolution of tumours in the PCAWG dataset, we applied this analysis to the 2,116 samples with copy number gains suitable for timing (Supplementary Information). We find that chromosomal gains occur across a wide range of molecular times (median molecular time 0.60, interquartile range (IQR) 0.10–0.87), with systematic differences between tumour types, whereas within tumour types, different chromosomes typically show similar distributions (Fig. 1c, Extended Data Figs. 1, 2, Supplementary Information). In glioblastoma and medulloblastoma, a substantial fraction of gains occurs early in molecular time. By contrast, in lung cancers, melanomas and papillary kidney cancers, gains arise towards the end of the molecular timescale. Most tumour types, including breast, ovarian and colorectal cancers, show relatively broad periods of chromosomal instability, indicating a very variable timing of gains across samples.\n\nThere are, however, certain tumour types with consistently early or late gains of specific chromosomal regions. Most pronounced is glioblastoma, in which 90% of tumours contain single copy gains of chromosome 7, 19 or 20 (Fig. 1c, d). Notably, these gains are consistently timed within the first 10% of molecular time, which suggests that they arise very early in a patient’s lifetime. In the case of trisomy 7, typically less than 3 out of 600 single nucleotide variants (SNVs) on the whole chromosome precede the gain (Extended Data Fig. 3a, b). On the basis of a mutation rate of µ = 4.8 × 10−10 to 3.0 × 10−9 SNVs per base pair per division25, this indicates that the trisomy occurs within the first 6–39 cell divisions, suggesting a possible early developmental origin, in agreement with somatic mosaicisms observed in the healthy brain26. Similarly, the duplications leading to isochromosome 17q in medulloblastoma are timed exceptionally early (Extended Data Fig. 3c, d).\n\nNotably, we observed that gains in the same tumour often appear to occur at a similar molecular time, pointing towards punctuated bursts of copy number gains involving most gained segments (Fig. 1e). Although this is expected in tumours with WGD (Fig. 1b), it may seem surprising to observe synchronous gains in near-diploid tumours, particularly as only 6% of co-amplified chromosomal segments were linked by a direct inter-chromosomal structural variant. Still, synchronous gains are frequent, occurring in 57% (468 out of 815) of informative near-diploid tumours, 61% more frequently than expected by chance (P < 0.01, permutation test; Fig. 1f). Because most arm-level gains increment the allele-specific copy number by 1 (80–90%; Fig. 1g), it seems that these gains arise through mis-segregation of single copies during anaphase. This notion is further supported by the observation that in about 85% of segments with two gains of the same allele, the second gain appears with noticeable latency after the first (Fig. 1h). Therefore, the extensive chromosome-scale copy number aberrations observed in many cancer genomes are seemingly caused by a limited number of events—possibly by merotelic attachments of chromosomes to multipolar mitotic spindles27, or as a consequence of negative selection of individual aneuploidies28—offering an explanation for observations of punctuated evolution in breast and colorectal cancer29,30.\n\nTo our knowledge, our study presents the first large-scale genome-wide reconstruction of the evolutionary history of cancers, reconstructing both early (pre-cancer) and later stages of 38 cancer types. This is facilitated by the timing of copy number gains relative to all other events in the genome, through multiplicity and clonal status of co-amplified point mutations. However, several limitations exist (Supplementary Information). Perhaps most importantly, molecular timing is based on point mutations and is therefore subject to changes in mutation rate. Notably, healthy tissues acquire point mutations at rates not too dissimilar from those seen in cancers, particularly when considering only endogenous mutational processes, and furthermore, some tissues are riddled with microscopic clonal expansions of driver gene mutations5,6,7,8,9,11. This is direct evidence that the life history of almost every cell in the human body, including those that develop into cancer, is driven by somatic evolution.\n\nTogether, the data presented here enable us to draw approximate timelines summarizing the typical evolutionary history of each cancer type (Fig. 6, Supplementary Information for all other cancer types). These make use of the qualitative timing of point mutations and copy number alterations, as well as signature activities, which can be interleaved with the chronological estimates of WGD and the appearance of the MRCA.\n\nIt is remarkable that the evolution of practically all cancers displays some level of order, which agrees very well with, and adds much detail to, established models of cancer progression35,46. For example, TP53 with accompanying 17p deletion is one of the most frequent initiating mutations in a variety of cancers, including ovarian cancer, in which it is the hallmark of its precancerous precursor lesions47. Furthermore, the list of typically early drivers includes most other highly recurrent cancer genes, such as KRAS, TERT and CDKN2A, indicating a preferred role in early and possibly even pre-cancer evolution. This initially constrained set of genes broadens at later stages of cancer development, suggesting an epistatic fitness landscape canalizing the first steps of cancer evolution. Over time, as tumours evolve, they follow increasingly diverse paths driven by individually rare driver mutations, and by copy number alternations. However, none of these trends is absolute, and the evolutionary paths of individual tumours are highly variable, showing that cancer evolution follows trends, but is far from deterministic.\n\nOur study sheds light on the typical timescales of in vivo tumour development, with initial driver events seemingly occurring up to decades before diagnosis, demonstrating how cancer genomes are shaped by a lifelong process of somatic evolution, with fluid boundaries between normal ageing processes5,6,7,8,9,10,11 and cancer evolution. Nevertheless, the presence of genetic aberrations with such long latency raises hopes that aberrant clones could be detected early, before reaching their full malignant potential.\n\nDataset\n\nThe PCAWG series consists of 2,778 tumour samples (2,703 white listed, 75 grey listed) from 2,658 donors. All samples in this dataset underwent whole-genome sequencing (minimum average coverage 30× in the tumour, 25× in the matched normal samples), and were processed with a set of project-specific pipelines for alignment, variant calling, and quality control4. Copy number calls were established by combining the output of six individual callers into a consensus using a multi-tier approach, resulting in a copy number profile, a purity and ploidy value and whether the tumour has undergone a WGD (Supplementary Information). Consensus subclonal architectures have been obtained by integrating the output of 11 subclonal reconstruction callers, after which all SNVs, indels and structural variants are assigned to a mutation cluster using the MutationTimer.R approach (Supplementary Information). Driver calls have been defined by the PCAWG Driver Working Group4, and mutational signatures are defined by the PCAWG Signatures Working Group24. A more detailed description can be found in Supplementary Information, section 1.\n\nData accrual was based on sequencing experiments performed by individual member groups of the ICGC and TCGA, as described in an associated study4. As this is a meta-analysis of existing data, power calculations were not performed and the investigators were not blinded to cancer diagnoses.\n\nTiming of gains\n\nWe used three related approaches to calculate the timing of copy number gains (see Supplementary Information, section 2). In brief, the common feature is that the expected VAF of a mutation (E) is related to the underlying number of alleles carrying a mutation according to the formula: E[X] = nmfρ/[N (1 − ρ) + Cρ], in which X is the number of reads, n denotes the coverage of the locus, the mutation copy number m is the number of alleles carrying the mutation (which is usually inferred), f is the frequency of the clone carrying the given mutation (f = 1 for clonal mutations). N is the normal copy number (2 on autosomes, 1 or 2 for chromosome X and 0 or 1 for chromosome Y), C is the total copy number of the tumour, and ρ is the purity of the sample.\n\nThe number of mutations nm at each allelic copy number m then informs about the time when the gain has occurred. The basic formulae for timing each gain are, depending on the copy number configuration:\n\n$${\\rm{Copy}}\\,{\\rm{number}}\\,2+1:T=3{n}_{2}/(2{n}_{2}+{n}_{1})$$\n\n$${\\rm{Copy}}\\,{\\rm{number}}\\,2+2:T=2{n}_{2}/(2{n}_{2}+{n}_{1})$$\n\nin which 2 + 1 refers to major and minor copy number of 2 and 1, respectively. Methods differ slightly in how the number of mutations present on each allele are calculated and how uncertainty is handled (Supplementary Information).\n\nTiming of mutations\n\nThe mutation copy number m and the clonal frequency f is calculated according to the principles indicated above. Details can be found in Supplementary Information, section 2. Mutations with f = 1 are denoted as ‘clonal’, and mutations with f < 1 as ‘subclonal’. Mutations with f = 1 and m > 1 are denoted as ‘early clonal’ (co-amplified). In cases with f = 1, m = 1 and C > 2, mutations were annotated as ‘late clonal’, if the minor copy number was 0, otherwise ‘clonal’ (unspecified).\n\nTiming of driver mutations\n\nA catalogue of driver point mutations (SNVs and indels) was provided by the PCAWG Drivers and Functional Interpretation Group4. The timing category was calculated as above. From the four timing categories, the odds ratios of early/late clonal and clonal (early, late or unspecified clonal)/subclonal were calculated for driver mutations against the distribution of all other mutations present in fragments with the same copy number composition in the samples with each particular driver. The background distribution of these odds ratios was assessed with 1,000 bootstraps (Supplementary Information, section 4.1).\n\nIntegrative timing\n\nFor each pair of driver point mutations and recurrent copy number alterations, an ordering was established (earlier, later or unspecified). The information underlying this decision was derived from the timing of each driver point mutation, as well as from the timing status of clonal and subclonal copy number segments. These tables were aggregated across all samples and a sports statistics model was employed to calculate the overall ranking of driver mutations. A full description is given in Supplementary Information, section 4.2.\n\nTiming of mutational signatures\n\nMutational trinucleotide substitution signatures, as defined by the PCAWG Mutational Signatures Working Group24, were fit to samples with observed signature activity, after splitting point mutations into either of the four epochs. A likelihood ratio test based on the multinomial distribution was used to test for differences in the mutation spectra between time points. Time-resolved exposures were calculated using non-negative linear least squares. Full details are given in Supplementary Information, section 5.\n\nReal-time estimation of WGD and MRCA\n\nCpG>TpG mutations were counted in an NpCpG context, except for skin–melanoma, in which CpCpG and TpCpG were excluded owing to the overlapping UV mutation spectrum. For visual comparison, the number of mutations was scaled to the effective genome size, defined as the 1/mean(mi/Ci), in which mi is the estimated number of allelic copies of each mutation, and Ci is the total copy number at that locus, thereby scaling to the final copy number and the time of change.\n\nA hierarchical Bayesian linear regression was fit to relate the age at diagnosis to the scaled number of mutations, ensuring positive slope and intercept through a shared gamma distribution across cancer types.\n\nFor tumours with several time points, the set of mutations shared between diagnosis and relapse (nD) and those specific to the relapse (nR) was calculated. The rate acceleration was calculated as: a = nR/nD × tD/tR. This analysis was performed separately for all substitutions and for CpG>TpG mutations.\n\nOn the basis of these analyses, a typical increase of 5× for most cancer types was chosen, with a lower value of 2.5× for brain cancers and a value of 7.5× for ovarian cancer.\n\nThe correction for transforming an estimate of a copy number gain in mutation time into chronological time depends not only on the rate acceleration, but also on the time at which this acceleration occurred. As this is generally unknown, we performed Monte Carlo simulations of rate accelerations spanning an interval of 15 years before diagnosis, corresponding roughly to 25% of time for a diagnosis at 60 years of age, noting that a 5× rate increase over this duration yields an offset of about 33% of mutations, compatible with our data. Subclonal mutations were assumed to occur at full acceleration. The proportion of subclonal mutations was divided by the number of identified subclones, thus conservatively assuming branching evolution. Full details are given in Supplementary Information, section 6.\n\nCancer timelines\n\nThe results from each of the different timing analyses are combined in timelines of cancer evolution for each tumour type (Fig. 6 and Supplementary Information). Each timeline begins at the fertilized egg, and spans up to the median age of diagnosis within each cohort. Real-time estimates for WGD and the MRCA act as anchor points, allowing us to roughly map the four broadly defined time periods (early clonal, intermediate, late clonal and subclonal) to chronological time during a patient’s lifespan. Specific driver mutations or copy number alterations can be placed within each of these time frames based on their ordering from the league model analysis. Signatures are shown if they typically change over time (95% confidence intervals of mean change not overlapping 0), and if they are strongly active (contributing at least 10% mutations to one time point). Signatures are shown on the timeline in the epoch of their greatest activity. Where an event found in our study has a known timing in the literature, the agreement is annotated on the timeline; with an asterisk denoting an agreed timing, and dagger symbol denoting a timing that is different to our results. Full details are given in Supplementary Information, section 7.\n\nReporting summary\n\nFurther information on research design is available in the Nature Research Reporting Summary linked to this paper.\n\nAuthor notes\n\nThese authors contributed equally: Moritz Gerstung, Clemency Jolly, Ignaty Leshchiner, Stefan C. Dentro, Santiago Gonzalez\n\nThese authors jointly supervised this work: Paul T. Spellman, David C. Wedge, Peter Van Loo\n\nA list of members and their affiliations appears at the end of the paper\n\nA list of members and their affiliations appears online\n\nAuthors and Affiliations\n\nEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK\n\nMoritz Gerstung, Santiago Gonzalez, Lara Jerman, Moritz Gerstung, Santiago Gonzalez & Lara Jerman\n\nEuropean Molecular Biology Laboratory, Genome Biology Unit, Heidelberg, Germany\n\nMoritz Gerstung & Moritz Gerstung\n\nWellcome Sanger Institute, Cambridge, UK\n\nMoritz Gerstung, Stefan C. Dentro, Thomas J. Mitchell, Maxime Tarabichi, Ignacio Vázquez-García, Stefan C. Dentro, Moritz Gerstung, Maxime Tarabichi, David J. Adams, Peter J. Campbell, Kevin J. Dawson, Henry Lee-Six, Inigo Martincorena, Thomas J. Mitchell & Ignacio Vázquez-García\n\nThe Francis Crick Institute, London, UK\n\nClemency Jolly, Stefan C. Dentro, Maxime Tarabichi, Kerstin Haase, Jonas Demeulemeester, Stefan C. Dentro, Clemency Jolly, Kerstin Haase, Maxime Tarabichi, Jonas Demeulemeester, Matthew Fittall, Peter Van Loo & Peter Van Loo\n\nBroad Institute of MIT and Harvard, Cambridge, MA, USA\n\nIgnaty Leshchiner, Daniel Rosebrock, Dimitri G. Livitz, Steven Schumacher, Gad Getz, Rameen Beroukhim, Ignaty Leshchiner, Rameen Beroukhim, Gad Getz, Gavin Ha, Dimitri G. Livitz, Daniel Rosebrock, Steven Schumacher & Oliver Spiro\n\nBig Data Institute, University of Oxford, Oxford, UK\n\nStefan C. Dentro, Stefan C. Dentro, David C. Wedge & David C. Wedge\n\nUniversity of Cambridge, Cambridge, UK\n\nThomas J. Mitchell, Ignacio Vázquez-García, Thomas J. Mitchell & Ignacio Vázquez-García\n\nUniversity of Toronto, Toronto, Ontario, Canada\n\nYulia Rubanova, Amit Deshwar, Jeff Wintersinger, Paul C. Boutros, Quaid D. Morris, Jeff Wintersinger, Amit G. Deshwar, Yulia Rubanova, Paul C. Boutros, Ruian Shi, Shankar Vembu & Quaid D. Morris\n\nVector Institute, Toronto, Ontario, Canada\n\nYulia Rubanova, Amit Deshwar, Jeff Wintersinger, Quaid D. Morris, Jeff Wintersinger, Amit G. Deshwar, Yulia Rubanova & Quaid D. Morris\n\nMolecular and Medical Genetics, Oregon Health & Science University, Portland, OR, USA\n\nPavana Anur, Pavana Anur, Myron Peto, Paul T. Spellman & Paul T. Spellman\n\nThe University of Texas MD Anderson Cancer Center, Houston, TX, USA\n\nKaixian Yu, Yu Fan, Hongtu Zhu, Wenyi Wang, Kaixian Yu, Shaolong Cao, Yu Fan, Seung Jun Shin, Hongtu Zhu & Wenyi Wang\n\nGerman Cancer Research Center (DKFZ), Heidelberg, Germany\n\nKortine Kleinheinz, Matthias Schlesner, Roland Eils, Kortine Kleinheinz & Matthias Schlesner\n\nHeidelberg University, Heidelberg, Germany\n\nKortine Kleinheinz, Roland Eils & Kortine Kleinheinz\n\nUniversity of Ljubljana, Ljubljana, Slovenia\n\nLara Jerman & Lara Jerman\n\nNorthShore University HealthSystem, Evanston, IL, USA\n\nSubhajit Sengupta, Yuan Ji, Yuan Ji & Subhajit Sengupta\n\nCancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK\n\nGeoff Macintyre, Florian Markowetz, Ke Yuan, Geoff Macintyre, Ruben M. Drews, Florian Markowetz & Ke Yuan\n\nSimon Fraser University, Burnaby, British Columbia, Canada\n\nSalem Malikic, Nilgun Donmez, Nilgun Donmez & Salem Malikic\n\nVancouver Prostate Centre, Vancouver, British Columbia, Canada\n\nSalem Malikic, Nilgun Donmez, S. Cenk Sahinalp, Nilgun Donmez, Salem Malikic & S. Cenk Sahinalp\n\nUniversity of Melbourne, Melbourne, Victoria, Australia\n\nMarek Cmero, Elizabeth L. Christie, Marek Cmero & Dale W. Garsed\n\nWalter and Eliza Hall Institute, Melbourne, Victoria, Australia\n\nMarek Cmero & Marek Cmero\n\nUniversity of Leuven, Leuven, Belgium\n\nJonas Demeulemeester, Jonas Demeulemeester, Peter Van Loo & Peter Van Loo\n\nWeill Cornell Medicine, New York, NY, USA\n\nXiaotong Yao, Marcin Imielinski, Marcin Imielinski & Xiaotong Yao\n\nNew York Genome Center, New York, NY, USA\n\nXiaotong Yao, Marcin Imielinski, Marcin Imielinski & Xiaotong Yao\n\nUniversity of California Santa Cruz, Santa Cruz, CA, USA\n\nJuhee Lee & Juhee Lee\n\nOntario Institute for Cancer Research, Toronto, Ontario, Canada\n\nPaul C. Boutros, Paul C. Boutros, Adriana Salcedo & Lincoln D. Stein\n\nUniversity of California, Los Angeles, CA, USA\n\nPaul C. Boutros & Paul C. Boutros\n\nPeter MacCallum Cancer Centre, Melbourne, Victoria, Australia\n\nDavid D. Bowtell, David D. Bowtell, Elizabeth L. Christie & Dale W. Garsed\n\nCenter for Cancer Research, Massachusetts General Hospital, Charlestown, MA, USA\n\nGad Getz & Gad Getz\n\nDepartment of Pathology, Massachusetts General Hospital, Boston, MA, USA\n\nGad Getz & Gad Getz\n\nHarvard Medical School, Boston, MA, USA\n\nGad Getz & Gad Getz\n\nDana-Farber Cancer Institute, Boston, MA, USA\n\nRameen Beroukhim & Rameen Beroukhim\n\nIndiana University, Bloomington, IN, USA\n\nS. Cenk Sahinalp & S. Cenk Sahinalp\n\nThe University of Chicago, Chicago, IL, USA\n\nYuan Ji & Yuan Ji\n\nUniversity of Cologne, Cologne, Germany\n\nMartin Peifer, Yupeng Cun, Martin Peifer & Tsun-Po Yang\n\nUniversity of Helsinki, Helsinki, Finland\n\nVille Mustonen & Ville Mustonen\n\nUniversity of Glasgow, Glasgow, UK\n\nKe Yuan & Ke Yuan\n\nOxford NIHR Biomedical Research Centre, Oxford, UK\n\nDavid C. Wedge & David C. Wedge\n\nDepartment of Computer Science, Carleton College, Northfield, MN, USA\n\nLayla Oesper\n\nDepartment of Computer Science, Princeton University, Princeton, NJ, USA\n\nBenjamin J. Raphael\n\nKorea University, Seoul, South Korea\n\nSeung Jun Shin\n\nHuman Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA\n\nDavid A. Wheeler\n\nApplied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland\n\nLauri A. Aaltonen\n\nWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK\n\nFederico Abascal, David J. Adams, Ludmil B. Alexandrov, Sam Behjati, Shriram G. Bhosle, David T. Bowen, Adam P. Butler, Peter J. Campbell, Peter Clapham, Helen Davies, Kevin J. Dawson, Stefan C. Dentro, Serge Serge, Erik Garrison, Mohammed Ghori, Dominik Glodzik, Jonathan Hinton, David R. Jones, Young Seok Ju, Stian Knappskog, Barbara Kremeyer, Henry Lee-Six, Daniel A. Leongamornlert, Yilong Li, Sancha Martin, Iñigo Martincorena, Ultan McDermott, Andrew Menzies, Thomas J. Mitchell, Sandro Morganella, Jyoti Nangalia, Jonathan Nicholson, Serena Nik-Zainal, Sarah O’Meara, Elli Papaemmanuil, Keiran M. Raine, Manasa Ramakrishna, Kamna Ramakrishnan, Nicola D. Roberts, Rebecca Shepherd, Lucy Stebbings, Michael R. Stratton, Maxime Tarabichi, Jon W. Teague, Ignacio Vázquez-García, David C. Wedge, Lucy Yates, Jorge Zamora & Xueqing Zou\n\nMemorial Sloan Kettering Cancer Center, New York, NY, USA\n\nAdam Abeshouse, Hikmat Al-Ahmadie, Gunes Gundem, Zachary Heins, Jason Huse, Douglas A. Levine, Eric Minwei Liu & Angelica Ochoa\n\nGenome Science Division, Research Center for Advanced Science and Technology, University of Tokyo, Tokyo, Japan\n\nHiroyuki Aburatani, Genta Nagae, Akihiro Suzuki, Kenji Tatsuno & Shogo Yamamoto\n\nDepartment of Surgery, University of Chicago, Chicago, IL, USA\n\nNishant Agrawal\n\nDepartment of Surgery, Division of Hepatobiliary and Pancreatic Surgery, School of Medicine, Keimyung University Dongsan Medical Center, Daegu, South Korea\n\nKeun Soo Ahn & Koo Jeong Kang\n\nDepartment of Oncology, Gil Medical Center, Gachon University, Incheon, South Korea\n\nSung-Min Ahn\n\nHiroshima University, Hiroshima, Japan\n\nHiroshi Aikata, Koji Arihiro, Kazuaki Chayama, Yoshiiku Kawakami & Hideki Ohdan\n\nDepartment of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA\n\nRehan Akbani, Shaolong Cao, Yiwen Chen, Zechen Chong, Yu Fan, Jun Li, Han Liang, Wenyi Wang, Yumeng Wang & Yuan Yuan\n\nUniversity of Texas MD Anderson Cancer Center, Houston, TX, USA\n\nKadir C. Akdemir & Ken Chen\n\nKing Faisal Specialist Hospital and Research Centre, Al Maather, Riyadh, Saudi Arabia\n\nSultan T. Al-Sedairy\n\nBioinformatics Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain\n\nFatima Al-Shahrour & Elena Piñeiro-Yáñez\n\nBioinformatics Core Facility, University Medical Center Hamburg, Hamburg, Germany\n\nMalik Alawi\n\nHeinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany\n\nMalik Alawi & Adam Grundhoff\n\nOntario Tumour Bank, Ontario Institute for Cancer Research, Toronto, ON, Canada\n\nMonique Albert & John Bartlett\n\nDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA\n\nKenneth Aldape, Russell R. Broaddus, Bogdan Czerniak, Adel El-Naggar, Savitri Krishnamurthy, Alexander J. Lazar & Xiaoping Su\n\nLaboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA\n\nKenneth Aldape\n\nDepartment of Cellular and Molecular Medicine and Department of Bioengineering, University of California San Diego, La Jolla, CA, USA\n\nLudmil B. Alexandrov & Erik N. Bergstrom\n\nUC San Diego Moores Cancer Center, San Diego, CA, USA\n\nLudmil B. Alexandrov, Erik N. Bergstrom & Olivier Harismendy\n\nCanada’s Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada\n\nAdrian Ally, Miruna Balasundaram, Reanne Bowlby, Denise Brooks, Rebecca Carlsen, Eric Chuah, Noreen Dhalla, Robert A. Holt, Steven J. M. Jones, Katayoon Kasaian, Darlene Lee, Haiyan Irene Li, Yussanne Ma, Marco A. Marra, Michael Mayo, Richard A. Moore, Andrew J. Mungall, Karen Mungall, A. Gordon Robertson, Sara Sadeghi, Jacqueline E. Schein, Payal Sipahimalani, Angela Tam, Nina Thiessen & Tina Wong\n\nSir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia\n\nKathryn Alsop, David D. L. Bowtell, Elizabeth L. Christie, Dariush Etemadmoghadam, Sian Fereday, Dale W. Garsed, Linda Mileshkin, Chris Mitchell, Mark Shackleton, Heather Thorne & Nadia Traficante\n\nCentre for Research in Molecular Medicine and Chronic Diseases (CiMUS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain\n\nEva G. Alvarez, Alicia L. Bruzos, Bernardo Rodriguez-Martin, Javier Temes, Jose M. C. Tubio & Jorge Zamora\n\nDepartment of Zoology, Genetics and Physical Anthropology, (CiMUS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain\n\nEva G. Alvarez, Alicia L. Bruzos, Bernardo Rodriguez-Martin, Javier Temes, Jose M. C. Tubio & Jorge Zamora\n\nThe Biomedical Research Centre (CINBIO), Universidade de Vigo, Vigo, Spain\n\nEva G. Alvarez, Alicia L. Bruzos, Bernardo Rodriguez-Martin, Marta Tojo, Jose M. C. Tubio & Jorge Zamora\n\nRoyal National Orthopaedic Hospital - Bolsover, London, UK\n\nFernanda Amary\n\nDepartment of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA\n\nSamirkumar B. Amin, P. Andrew Futreal & Alexander J. Lazar\n\nQuantitative and Computational Biosciences Graduate Program, Baylor College of Medicine, Houston, TX, USA\n\nSamirkumar B. Amin, Han Liang & Yumeng Wang\n\nThe Jackson Laboratory for Genomic Medicine, Farmington, CT, USA\n\nSamirkumar B. Amin, Joshy George & Lucas Lochovsky\n\nGenome Informatics Program, Ontario Institute for Cancer Research, Toronto, ON, Canada\n\nBrice Aminou, Niall J. Byrne, Aurélien Chateigner, Nodirjon Fayzullaev, Vincent Ferretti, George L. Mihaiescu, Hardeep K. Nahal-Bose, Brian D. O’Connor, B. F. Francis Ouellette, Marc D. Perry, Kevin Thai, Qian Xiang, Christina K. Yung & Junjun Zhang\n\nInstitute of Human Genetics, Christian-Albrechts-University, Kiel, Germany\n\nOle Ammerpohl, Andrea Haake, Cristina López, Julia Richter & Rabea Wagener\n\nInstitute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany\n\nOle Ammerpohl, Sietse Aukema, Cristina López, Reiner Siebert & Rabea Wagener\n\nQueensland Centre for Medical Genomics, Institute for Molecular Bioscience, University of Queensland, St. Lucia, Brisbane, QLD, Australia\n\nMatthew J. Anderson, Timothy J. C. Bruxner, Angelika N. Christ, J. Lynn Fink, Ivon Harliwong, Karin S. Kassahn, David K. Miller, Alan J. Robertson & Darrin F. Taylor\n\nSalford Royal NHS Foundation Trust, Salford, UK\n\nYeng Ang, Hsiao-Wei Chen, Ritika Kundra & Francisco Sanchez-Vega\n\nDepartment of Surgery, Pancreas Institute, University and Hospital Trust of Verona, Verona, Italy\n\nDavide Antonello, Claudio Bassi, Narong Khuntikeo, Luca Landoni, Giuseppe Malleo, Giovanni Marchegiani, Neil D. Merrett, Marco Miotto, Salvatore Paiella, Antonio Pea, Paolo Pederzoli, Roberto Salvia, Jaswinder S. Samra, Elisabetta Sereni & Samuel Singer\n\nMolecular and Medical Genetics, OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA\n\nPavana Anur, Myron Peto & Paul T. Spellman\n\nDepartment of Molecular Oncology, BC Cancer Research Centre, Vancouver, BC, Canada\n\nSamuel Aparicio\n\nThe McDonnell Genome Institute at Washington University, St. Louis, MO, USA\n\nElizabeth L. Appelbaum, Matthew H. Bailey, Matthew G. Cordes, Li Ding, Catrina C. Fronick, Lucinda A. Fulton, Robert S. Fulton, Kuan-lin Huang, Reyka Jayasinghe, Elaine R. Mardis, R. Jay Mashl, Michael D. McLellan, Christopher A. Miller, Heather K. Schmidt, Jiayin Wang, Michael C. Wendl, Richard K. Wilson & Tina Wong\n\nUniversity College London, London, UK\n\nElizabeth L. Appelbaum, Jonathan D. Kay, Helena Kilpinen, Laurence B. Lovat, Hayley J. Luxton & Hayley C. Whitaker\n\nDivision of Cancer Genomics, National Cancer Center Research Institute, National Cancer Center, Tokyo, Japan\n\nYasuhito Arai, Natsuko Hama, Fumie Hosoda, Hiromi Nakamura, Tatsuhiro Shibata, Yasushi Totoki & Shinichi Yachida\n\nDLR Project Management Agency, Bonn, Germany\n\nAxel Aretz\n\nTokyo Women’s Medical University, Tokyo, Japan\n\nShun-ichi Ariizumi & Masakazu Yamamoto\n\nCenter for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA\n\nJoshua Armenia, Hsiao-Wei Chen, Jianjiong Gao, Ritika Kundra, Francisco Sanchez-Vega, Nikolaus Schultz & Hongxin Zhang\n\nLos Alamos National Laboratory, Los Alamos, NM, USA\n\nLaurent Arnould\n\nDepartment of Pathology, University Health Network, Toronto General Hospital, Toronto, ON, Canada\n\nSylvia Asa, Michael H. A. Roehrl & Theodorus Van der Kwast\n\nNottingham University Hospitals NHS Trust, Nottingham, UK\n\nSylvia Asa, Simon L. Parsons & Ming Tsao\n\nEpigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), Heidelberg, Germany\n\nYassen Assenov\n\nComputational Biology Program, Ontario Institute for Cancer Research, Toronto, ON, Canada\n\nGurnit Atwal, Philip Awadalla, Jonathan Barenboim, Vinayak Bhandari, Ivan Borozan, Paul C. Boutros, Lewis Jonathan Dursi, Shadrielle M. G. Espiritu, Natalie S. Fox, Michael Fraser, Syed Haider, Vincent Huang, Keren Isaev, Wei Jiao, Christopher M. Lalansingh, Emilie Lalonde, Fabien C. Lamaze, Constance H. Li, Julie Livingstone, Christine P’ng, Marta Paczkowska, Stephenie D. Prokopec, Jüri Reimand, Veronica Y. Sabelnykova, Adriana Salcedo, Yu-Jia Shiah, Solomon I. Shorser, Shimin Shuai, Jared T. Simpson, Lincoln D. Stein, Ren X. Sun, Lina Wadi, Gavin W. Wilson, Adam J. Wright, Takafumi N. Yamaguchi, Fouad Yousif & Denis Yuen\n\nDepartment of Molecular Genetics, University of Toronto, Toronto, ON, Canada\n\nGurnit Atwal, Philip Awadalla, Gary D. Bader, Shimin Shuai & Lincoln D. Stein\n\nVector Institute, Toronto, ON, Canada\n\nGurnit Atwal, Quaid D. Morris, Yulia Rubanova & Jeffrey A. Wintersinger\n\nHematopathology Section, Institute of Pathology, Christian-Albrechts-University, Kiel, Germany\n\nSietse Aukema, Wolfram Klapper, Julia Richter & Monika Szczepanowski\n\nDepartment of Pathology and Laboratory Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA\n\nJ. Todd Auman & Charles M. Perou\n\nDepartment of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway\n\nMiriam R. R. Aure, Anne-Lise Børresen-Dale & Anita Langerød\n\nPathology, Hospital Clinic, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain\n\nMarta Aymerich\n\nDepartment of Veterinary Medicine, Transmissible Cancer Group, University of Cambridge, Cambridge, UK\n\nAdrian Baez-Ortega\n\nAlvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA\n\nMatthew H. Bailey, Li Ding, Robert S. Fulton, Ramaswamy Govindan & Michael D. McLellan\n\nWolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK\n\nPeter J. Bailey, Andrew V. Biankin, David K. Chang, Susanna L. Cooke, Fraser R. Duthie, Janet S. Graham, Nigel B. Jamieson, Elizabeth A. Musgrove & Derek W. Wright\n\nLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA\n\nSaianand Balu, Tom Bodenheimer, D. Neil Hayes, Austin J. Hepperla, Katherine A. Hoadley, Alan P. Hoyle, Stuart R. Jefferys, Shaowu Meng, Lisle E. Mose, Grant Sanders, Yan Shi, Janae V. Simons & Matthew G. Soloway\n\nBroad Institute of MIT and Harvard, Cambridge, MA, USA\n\nPratiti Bandopadhayay, Rameen Beroukhim, Angela N. Brooks, Susan Bullman, John Busanovich, Andrew D. Cherniack, Juok Cho, Carrie Cibulskis, Kristian Cibulskis, David Craft, Timothy Defreitas, Andrew J. Dunford, Scott Frazer, Stacey B. Gabriel, Nils Gehlenborg, Gad Getz, Manaswi Gupta, Gavin Ha, Nicholas J. Haradhvala, David I. Heiman, Julian M. Hess, Manolis Kellis, Jaegil Kim, Kiran Kumar, Kirsten Kübler, Eric Lander, Michael S. Lawrence, Ignaty Leshchiner, Pei Lin, Ziao Lin, Dimitri Livitz, Yosef E. Maruvka, Samuel R. Meier, Matthew Meyerson, Michael S. Noble, Chandra Sekhar Pedamallu, Paz Polak, Esther Rheinbay, Daniel Rosebrock, Mara Rosenberg, Gordon Saksena, Richard Sallari, Steven E. Schumacher, Ayellet V. Segre, Ofer Shapira, Juliann Shih, Nasa Sinnott-Armstrong, Oliver Spiro, Chip Stewart, Amaro Taylor-Weiner, Grace Tiao, Douglas Voet, Jeremiah A. Wala, Cheng-Zhong Zhang & Hailei Zhang\n\nDana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, MA, USA\n\nPratiti Bandopadhayay\n\nDepartment of Pediatrics, Harvard Medical School, Boston, MA, USA\n\nPratiti Bandopadhayay\n\nLeeds Institute of Medical Research @ St. James’s, University of Leeds, St. James’s University Hospital, Leeds, UK\n\nRosamonde E. Banks & Naveen Vasudev\n\nDepartment of Pathology and Diagnostics, University and Hospital Trust of Verona, Verona, Italy\n\nStefano Barbi, Vincenzo Corbo & Michele Simbolo\n\nDepartment of Surgery, Princess Alexandra Hospital, Brisbane, QLD, Australia\n\nAndrew P. Barbour\n\nSurgical Oncology Group, Diamantina Institute, University of Queensland, Brisbane, QLD, Australia\n\nAndrew P. Barbour\n\nDepartment of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA\n\nJill Barnholtz-Sloan\n\nResearch Health Analytics and Informatics, University Hospitals Cleveland Medical Center, Cleveland, OH, USA\n\nJill Barnholtz-Sloan\n\nGloucester Royal Hospital, Gloucester, UK\n\nHugh Barr\n\nEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK\n\nElisabet Barrera, Wojciech Bazant, Ewan Birney, Rich Boyce, Alvis Brazma, Andy Cafferkey, Claudia Calabrese, Paul Flicek, Nuno A. Fonseca, Anja Füllgrabe, Moritz Gerstung, Santiago Gonzalez, Liliana Greger, Maria Keays, Jan O. Korbel, Alfonso Muñoz, Steven J. Newhouse, David Ocana, Irene Papatheodorou, Robert Petryszak, Roland F. Schwarz, Charles Short, Oliver Stegle & Lara Urban\n\nDiagnostic Development, Ontario Institute for Cancer Research, Toronto, ON, Canada\n\nJohn Bartlett & Ilinca Lungu\n\nBarcelona Supercomputing Center (BSC), Barcelona, Spain\n\nJavier Bartolome, Mattia Bosio, Ana Dueso-Barroso, J. Lynn Fink, Josep L. L. Gelpi, Ana Milovanovic, Montserrat Puiggròs, Javier Bartolomé Rodriguez, Romina Royo, David Torrents, Alfonso Valencia, Miguel Vazquez, David Vicente & Izar Villasante\n\nArnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada\n\nOliver F. Bathe\n\nDepartments of Surgery and Oncology, University of Calgary, Calgary, AB, Canada\n\nOliver F. Bathe\n\nDepartment of Pathology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway\n\nDaniel Baumhoer & Bodil Bjerkehagen\n\nPanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, ON, Canada\n\nPrashant Bavi, Michelle Chan-Seng-Yue, Sean Cleary, Robert E. Denroche, Steven Gallinger, Robert C. Grant, Gun Ho Jang, Sangeetha Kalimuthu, Ilinca Lungu, John D. McPherson, Faiyaz Notta, Michael H. A. Roehrl, Gavin W. Wilson & Julie M. Wilson\n\nDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine, Baltimore, MD, USA\n\nStephen B. Baylin, Nilanjan Chatterjee, Leslie Cope, Ludmila Danilova & Ralph H. Hruban\n\nUniversity Hospital Southampton NHS Foundation Trust, Southampton, UK\n\nStephen B. Baylin & Tim Dudderidge\n\nRoyal Stoke University Hospital, Stoke-on-Trent, UK\n\nDuncan Beardsmore & Christopher Umbricht\n\nGenome Sequence Informatics, Ontario Institute for Cancer Research, Toronto, ON, Canada\n\nTimothy A. Beck, Bob Gibson, Lawrence E. Heisler, Xuemei Luo & Morgan L. Taschuk\n\nHuman Longevity Inc, San Diego, CA, USA\n\nTimothy A. Beck\n\nOlivia Newton-John Cancer Research Institute, La Trobe University, Heidelberg, VIC, Australia\n\nAndreas Behren & Jonathan Cebon\n\nComputer Network Information Center, Chinese Academy of Sciences, Beijing, China\n\nBeifang Niu\n\nGenome Canada, Ottawa, ON, Canada\n\nCindy Bell\n\nCNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain\n\nSergi Beltran, Ivo G. Gut, Marta Gut, Simon C. Heath, Tomas Marques-Bonet, Arcadi Navarro, Miranda D. Stobbe, Jean-Rémi Trotta & Justin P. Whalley\n\nUniversitat Pompeu Fabra (UPF), Barcelona, Spain\n\nSergi Beltran, Mattia Bosio, German M. Demidov, Oliver Drechsel, Ivo G. Gut, Marta Gut, Simon C. Heath, Francesc Muyas, Stephan Ossowski, Aparna Prasad, Raquel Rabionet, Miranda D. Stobbe & Hana Susak\n\nBuck Institute for Research on Aging, Novato, CA, USA\n\nChristopher Benz & Christina Yau\n\nDuke University Medical Center, Durham, NC, USA\n\nAndrew Berchuck\n\nDepartment of Human Genetics, Hannover Medical School, Hannover, Germany\n\nAnke K. Bergmann\n\nCenter for Bioinformatics and Functional Genomics, Cedars-Sinai Medical Center, Los Angeles, CA, USA\n\nBenjamin P. Berman & Huy Q. Dinh\n\nDepartment of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA\n\nBenjamin P. Berman\n\nThe Hebrew University Faculty of Medicine, Jerusalem, Israel\n\nBenjamin P. Berman\n\nBarts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK\n\nDaniel M. Berney & Yong-Jie Lu\n\nDepartment of Computer Science, Bioinformatics Group, University of Leipzig, Leipzig, Germany\n\nStephan H. Bernhart, Hans Binder, Steve Hoffmann & Peter F. Stadler\n\nInterdisciplinary Center for Bioinformatics, University of Leipzig, Leipzig, Germany\n\nStephan H. Bernhart, Hans Binder, Steve Hoffmann, Helene Kretzmer & Peter F. Stadler\n\nTranscriptome Bioinformatics, LIFE Research Center for Civilization Diseases, University of Leipzig, Leipzig, Germany\n\nStephan H. Bernhart, Steve Hoffmann, Helene Kretzmer & Peter F. Stadler\n\nDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA\n\nRameen Beroukhim, Angela N. Brooks, Susan Bullman, Andrew D. Cherniack, Levi Garraway, Matthew Meyerson, Chandra Sekhar Pedamallu, Steven E. Schumacher, Juliann Shih & Jeremiah A. Wala\n\nDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA\n\nRameen Beroukhim, Aquila Fatima, Andrea L. Richardson, Steven E. Schumacher, Ofer Shapira, Andrew Tutt & Jeremiah A. Wala\n\nHarvard Medical School, Boston, MA, USA\n\nRameen Beroukhim, Gad Getz, Kirsten Kübler, Matthew Meyerson, Chandra Sekhar Pedamallu, Paz Polak, Esther Rheinbay & Jeremiah A. Wala\n\nUSC Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA\n\nMario Berrios, Moiz S. Bootwalla, Andrea Holbrook, Phillip H. Lai, Dennis T. Maglinte, David J. Van Den Berg & Daniel J. Weisenberger\n\nDepartment of Diagnostics and Public Health, University and Hospital Trust of Verona, Verona, Italy\n\nSamantha Bersani, Ivana Cataldo, Claudio Luchini & Maria Scardoni\n\nDepartment of Mathematics, Aarhus University, Aarhus, Denmark\n\nJohanna Bertl & Asger Hobolth\n\nDepartment of Molecular Medicine (MOMA), Aarhus University Hospital, Aarhus N, Denmark\n\nJohanna Bertl, Henrik Hornshøj, Malene Juul, Randi Istrup Juul, Tobias Madsen, Morten Muhlig Nielsen & Jakob Skou Pedersen\n\nInstituto Carlos Slim de la Salud, Mexico City, Mexico\n\nMiguel Betancourt\n\nDepartment of Medical Biophysics, University of Toronto, Toronto, ON, Canada\n\nVinayak Bhandari, Paul C. Boutros, Robert G. Bristow, Keren Isaev, Constance H. Li, Jüri Reimand, Michael H. A. Roehrl & Bradly G. Wouters\n\nCancer Division, Garvan Institute of Medical Research, Kinghorn Cancer Centre, University of New South Wales (UNSW Sydney), Sydney, NSW, Australia\n\nAndrew V. Biankin, David K. Chang, Lorraine A. Chantrill, Angela Chou, Anthony J. Gill, Amber L. Johns, James G. Kench, David K. Miller, Adnan M. Nagrial, Marina Pajic, Mark Pinese, Ilse Rooman, Christopher J. Scarlett, Christopher W. Toon & Jianmin Wu\n\nSouth Western Sydney Clinical School, Faculty of Medicine, University of New South Wales (UNSW Sydney), Liverpool, NSW, Australia\n\nAndrew V. Biankin\n\nWest of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, UK\n\nAndrew V. Biankin & Nigel B. Jamieson\n\nCenter for Digital Health, Berlin Institute of Health and Charitè - Universitätsmedizin Berlin, Berlin, Germany\n\nMatthias Bieg\n\nHeidelberg Center for Personalized Oncology (DKFZ-HIPO), German Cancer Research Center (DKFZ), Heidelberg, Germany\n\nMatthias Bieg, Ivo Buchhalter, Barbara Hutter & Nagarajan Paramasivam\n\nThe Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA\n\nDarell Bigner\n\nMassachusetts General Hospital, Boston, MA, USA\n\nMichael Birrer, Vikram Deshpande, William C. Faquin, Nicholas J. Haradhvala, Kirsten Kübler, Michael S. Lawrence, David N. Louis, Yosef E. Maruvka, G. Petur Nielsen, Esther Rheinbay, Mara Rosenberg, Dennis C. Sgroi & Chin-Lee Wu\n\nNational Institute of Biomedical Genomics, Kalyani, West Bengal, India\n\nNidhan K. Biswas, Arindam Maitra & Partha P. Majumder\n\nInstitute of Clinical Medicine and Institute of Oral Biology, University of Oslo, Oslo, Norway\n\nBodil Bjerkehagen\n\nUniversity of North Carolina at Chapel Hill, Chapel Hill, NC, USA\n\nLori Boice, Mei Huang, Sonia Puig & Leigh B. Thorne\n\nARC-Net Centre for Applied Research on Cancer, University and Hospital Trust of Verona, Verona, Italy\n\nGiada Bonizzato, Cinzia Cantù, Ivana Cataldo, Vincenzo Corbo, Sonia Grimaldi, Rita T. Lawlor, Andrea Mafficini, Borislav C. Rusev, Aldo Scarpa, Katarzyna O. Sikora, Nicola Sperandio, Alain Viari & Caterina Vicentini\n\nThe Institute of Cancer Research, London, UK\n\nJohann S. De Bono, Niedzica Camacho, Colin S. Cooper, Sandra E. Edwards, Rosalind A. Eeles, Zsofia Kote-Jarai, Daniel A. Leongamornlert, Lucy Matthews & Sue Merson\n\nCentre for Computational Biology, Duke-NUS Medical School, Singapore, Singapore\n\nArnoud Boot, Ioana Cutcutache, Mi Ni Huang, John R. McPherson, Steven G. Rozen & Yang Wu\n\nProgramme in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore, Singapore\n\nArnoud Boot, Ioana Cutcutache, Mi Ni Huang, John R. McPherson, Steven G. Rozen, Patrick Tan, Bin Tean Teh & Yang Wu\n\nDivision of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden\n\nAke Borg, Markus Ringnér & Johan Staaf\n\nDepartment of Pediatric Oncology, Hematology and Clinical Immunology, Heinrich-Heine-University, Düsseldorf, Germany\n\nArndt Borkhardt & Jessica I. Hoell\n\nLaboratory for Medical Science Mathematics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan\n\nKeith A. Boroevich, Todd A. Johnson, Michael S. Lawrence & Tatsuhiko Tsunoda\n\nRIKEN Center for Integrative Medical Sciences, Yokohama, Japan\n\nKeith A. Boroevich, Akihiro Fujimoto, Masashi Fujita, Mayuko Furuta, Kazuhiro Maejima, Hidewaki Nakagawa, Kaoru Nakano & Aya Sasaki-Oku\n\nDepartment of Internal Medicine/Hematology, Friedrich-Ebert-Hospital, Neumünster, Germany\n\nChristoph Borst & Siegfried Haas\n\nDepartments of Dermatology and Pathology, Yale University, New Haven, CT, USA\n\nMarcus Bosenberg\n\nCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain\n\nMattia Bosio, German M. Demidov, Oliver Drechsel, Georgia Escaramis, Xavier Estivill, Aliaksei Z. Holik, Francesc Muyas, Stephan Ossowski, Raquel Rabionet & Hana Susak\n\nRadcliffe Department of Medicine, University of Oxford, Oxford, UK\n\nJacqueline Boultwood\n\nCanadian Center for Computational Genomics, McGill University, Montreal, QC, Canada\n\nGuillaume Bourque\n\nDepartment of Human Genetics, McGill University, Montreal, QC, Canada\n\nGuillaume Bourque, Mark Lathrop & Yasser Riazalhosseini\n\nDepartment of Human Genetics, University of California Los Angeles, Los Angeles, CA, USA\n\nPaul C. Boutros\n\nDepartment of Pharmacology, University of Toronto, Toronto, ON, Canada\n\nPaul C. Boutros\n\nFaculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere University Hospital, Tampere, Finland\n\nG. Steven Bova & Tapio Visakorpi\n\nHaematology, Leeds Teaching Hospitals NHS Trust, Leeds, UK\n\nDavid T. Bowen\n\nTranslational Research and Innovation, Centre Léon Bérard, Lyon, France\n\nSandrine Boyault\n\nFox Chase Cancer Center, Philadelphia, PA, USA\n\nJeffrey Boyd & Elaine R. Mardis\n\nInternational Agency for Research on Cancer, World Health Organization, Lyon, France\n\nPaul Brennan & Ghislaine Scelo\n\nEarlham Institute, Norwich, UK\n\nDaniel S. Brewer & Colin S. Cooper\n\nNorwich Medical School, University of East Anglia, Norwich, UK\n\nDaniel S. Brewer & Colin S. Cooper\n\nDepartment of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University, Nijmegen, HB, The Netherlands\n\nArie B. Brinkman\n\nCRUK Manchester Institute and Centre, Manchester, UK\n\nRobert G. Bristow\n\nDepartment of Radiation Oncology, University of Toronto, Toronto, ON, Canada\n\nRobert G. Bristow\n\nDivision of Cancer Sciences, Manchester Cancer Research Centre, University of Manchester, Manchester, UK\n\nRobert G. Bristow\n\nRadiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON, Canada\n\nRobert G. Bristow & Fei-Fei Fei Liu\n\nDepartment of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA\n\nJane E. Brock & Sabina Signoretti\n\nDepartment of Surgery, Division of Thoracic Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA\n\nMalcolm Brock\n\nDivision of Molecular Pathology, The Netherlands Cancer Institute, Oncode Institute, Amsterdam, CX, The Netherlands\n\nAnnegien Broeks & Jos Jonkers\n\nDepartment of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, CA, USA\n\nAngela N. Brooks, David Haan, Maximillian G. Marin, Thomas J. Matthew, Yulia Newton, Cameron M. Soulette & Joshua M. Stuart\n\nUC Santa Cruz Genomics Institute, University of California Santa Cruz, Santa Cruz, CA, USA\n\nAngela N. Brooks, Brian Craft, Mary J. Goldman, David Haussler, Joshua M. Stuart & Jingchun Zhu\n\nDivision of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany\n\nBenedikt Brors, Lars Feuerbach, Chen Hong, Charles David Imbusch & Lina Sieverling\n\nGerman Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany\n\nBenedikt Brors, Barbara Hutter, Peter Lichter, Dirk Schadendorf & Holger Sültmann\n\nNational Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany\n\nBenedikt Brors, Barbara Hutter, Holger Sültmann & Thorsten Zenz\n\nCenter for Biological Sequence Analysis, Department of Bio and Health Informatics, Technical University of Denmark, Lyngby, Denmark\n\nSøren Brunak\n\nNovo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark\n\nSøren Brunak\n\nInstitute for Molecular Bioscience, University of Queensland, St. Lucia, Brisbane, QLD, Australia\n\nTimothy J. C. Bruxner, Oliver Holmes, Stephen H. Kazakoff, Conrad R. Leonard, Felicity Newell, Katia Nones, Ann-Marie Patch, John V. Pearson, Michael C. Quinn, Nick M. Waddell, Nicola Waddell, Scott Wood & Qinying Xu\n\nBiomedical Engineering, Oregon Health and Science University, Portland, OR, USA\n\nAlex Buchanan & Kyle Ellrott\n\nDivision of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany\n\nIvo Buchhalter, Calvin Wing Yiu Chan, Roland Eils, Michael C. Heinold, Carl Herrmann, Natalie Jäger, Rolf Kabbe, Jules N. A. Kerssemakers, Kortine Kleinheinz, Nagarajan Paramasivam, Manuel Prinz, Matthias Schlesner & Johannes Werner\n\nInstitute of Pharmacy and Molecular Biotechnology and BioQuant, Heidelberg University, Heidelberg, Germany\n\nIvo Buchhalter, Roland Eils, Michael C. Heinold, Carl Herrmann, Daniel Hübschmann, Kortine Kleinheinz & Umut H. Toprak\n\nFederal Ministry of Education and Research, Berlin, Germany\n\nChristiane Buchholz\n\nMelanoma Institute Australia, University of Sydney, Sydney, NSW, Australia\n\nHazel Burke, Ricardo De Paoli-Iseppi, Nicholas K. Hayward, Peter Hersey, Valerie Jakrot, Hojabr Kakavand, Georgina V. Long, Graham J. Mann, Robyn P. M. Saw, Richard A. Scolyer, Ping Shang, Andrew J. Spillane, Jonathan R. Stretch, John F. F. Thompson & James S. Wilmott\n\nPediatric Hematology and Oncology, University Hospital Muenster, Muenster, Germany\n\nBirgit Burkhardt\n\nDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA\n\nKathleen H. Burns & Christopher Umbricht\n\nMcKusick-Nathans Institute of Genetic Medicine, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine, Baltimore, MD, USA\n\nKathleen H. Burns\n\nFoundation Medicine, Inc, Cambridge, MA, USA\n\nJohn Busanovich\n\nDepartment of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, USA\n\nCarlos D. Bustamante & Francisco M. De La Vega\n\nDepartment of Genetics, Stanford University School of Medicine, Stanford, CA, USA\n\nCarlos D. Bustamante, Francisco M. De La Vega, Suyash S. Shringarpure, Nasa Sinnott-Armstrong & Mark H. Wright\n\nBakar Computational Health Sciences Institute and Department of Pediatrics, University of California, San Francisco, CA, USA\n\nAtul J. Butte & Jieming Chen\n\nInstitute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway\n\nAnne-Lise Børresen-Dale\n\nNational Cancer Institute, National Institutes of Health, Bethesda, MD, USA\n\nSamantha J. Caesar-Johnson, John A. Demchok, Ina Felau, Roy Tarnuzzer, Zhining Wang, Liming Yang, Jean C. Zenklusen & Jiashan Zhang\n\nRoyal Marsden NHS Foundation Trust, London and Sutton, UK\n\nDeclan Cahill, Nening M. Dennis, Tim Dudderidge, Rosalind A. Eeles, Cyril Fisher, Steven Hazell, Vincent Khoo, Pardeep Kumar, Naomi Livni, Erik Mayer, David Nicol, Christopher Ogden, Edward W. Rowe, Sarah Thomas, Alan Thompson & Nicholas van As\n\nGenome Biology Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany\n\nClaudia Calabrese, Serap Erkek, Moritz Gerstung, Santiago Gonzalez, Nina Habermann, Wolfgang Huber, Lara Jerman, Jan O. Korbel, Esa Pitkänen, Benjamin Raeder, Tobias Rausch, Vasilisa A. Rudneva, Oliver Stegle, Stephanie Sungalee, Lara Urban, Sebastian M. Waszak, Joachim Weischenfeldt & Sergei Yakneen\n\nDepartment of Oncology, University of Cambridge, Cambridge, UK\n\nCarlos Caldas & Suet-Feung Chin\n\nLi Ka Shing Centre, Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK\n\nCarlos Caldas, Suet-Feung Chin, Ruben M. Drews, Paul A. Edwards, Matthew Eldridge, Steve Hawkins, Andy G. Lynch, Geoff Macintyre, Florian Markowetz, Charlie E. Massie, David E. Neal, Simon Tavaré & Ke Yuan\n\nInstitut Gustave Roussy, Villejuif, France\n\nFabien Calvo\n\nCambridge University Hospitals NHS Foundation Trust, Cambridge, UK\n\nPeter J. Campbell, Vincent J. Gnanapragasam, William Howat, Thomas J. Mitchell, David E. Neal, Nimish C. Shah & Anne Y. Warren\n\nDepartment of Haematology, University of Cambridge, Cambridge, UK\n\nPeter J. Campbell\n\nAnatomia Patológica, Hospital Clinic, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain\n\nElias Campo\n\nSpanish Ministry of Science and Innovation, Madrid, Spain\n\nElias Campo\n\nUniversity of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA\n\nThomas E. Carey\n\nDepartment for BioMedical Research, University of Bern, Bern, Switzerland\n\nJoana Carlevaro-Fita\n\nDepartment of Medical Oncology, Inselspital, University Hospital and University of Bern, Bern, Switzerland\n\nJoana Carlevaro-Fita, Rory Johnson & Andrés Lanzós\n\nGraduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland\n\nJoana Carlevaro-Fita & Andrés Lanzós\n\nUniversity of Pavia, Pavia, Italy\n\nMario Cazzola & Luca Malcovati\n\nUniversity of Alabama at Birmingham, Birmingham, AL, USA\n\nRobert Cerfolio\n\nUHN Program in BioSpecimen Sciences, Toronto General Hospital, Toronto, ON, Canada\n\nDianne E. Chadwick, Sheng-Ben Liang, Michael H. A. Roehrl & Sagedeh Shahabi\n\nDepartment of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA\n\nDimple Chakravarty\n\nCentre for Law and Genetics, University of Tasmania, Sandy Bay Campus, Hobart, TAS, Australia\n\nDon Chalmers\n\nFaculty of Biosciences, Heidelberg University, Heidelberg, Germany\n\nCalvin Wing Yiu Chan, Chen Hong & Lina Sieverling\n\nDepartment of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada\n\nKin Chan\n\nDivision of Anatomic Pathology, Mayo Clinic, Rochester, MN, USA\n\nVishal S. Chandan\n\nDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA\n\nStephen J. Chanock, Xing Hua, Lisa Mirabello, Lei Song & Bin Zhu\n\nIllawarra Shoalhaven Local Health District L3 Illawarra Cancer Care Centre, Wollongong Hospital, Wollongong, NSW, Australia\n\nLorraine A. Chantrill\n\nBioForA, French National Institute for Agriculture, Food, and Environment (INRAE), ONF, Orléans, France\n\nAurélien Chateigner\n\nDepartment of Biostatistics, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA\n\nNilanjan Chatterjee\n\nUniversity of California San Diego, San Diego, CA, USA\n\nZhaohong Chen, Michelle T. Dow, Claudiu Farcas, S. M. Ashiqul Islam, Antonios Koures, Lucila Ohno-Machado, Christos Sotiriou & Ashley Williams\n\nDivision of Experimental Pathology, Mayo Clinic, Rochester, MN, USA\n\nJeremy Chien\n\nCentre for Cancer Research, The Westmead Institute for Medical Research, University of Sydney, Sydney, NSW, Australia\n\nYoke-Eng Chiew, Angela Chou, Jillian A. Hung, Catherine J. Kennedy, Graham J. Mann, Gulietta M. Pupo, Sarah-Jane Schramm, Varsha Tembe & Anna deFazio\n\nDepartment of Gynaecological Oncology, Westmead Hospital, Sydney, NSW, Australia\n\nYoke-Eng Chiew, Jillian A. Hung, Catherine J. Kennedy & Anna deFazio\n\nPDXen Biosystems Inc, Seoul, South Korea\n\nSunghoon Cho\n\nKorea Advanced Institute of Science and Technology, Daejeon, South Korea\n\nJung Kyoon Choi, Young Seok Ju & Christopher J. Yoon\n\nElectronics and Telecommunications Research Institute, Daejeon, South Korea\n\nWan Choi, Seung-Hyup Jeon, Hyunghwan Kim & Youngchoon Woo\n\nInstitut National du Cancer (INCA), Boulogne-Billancourt, France\n\nChristine Chomienne & Iris Pauporté\n\nDepartment of Genetics, Informatics Institute, University of Alabama at Birmingham, Birmingham, AL, USA\n\nZechen Chong\n\nDivision of Medical Oncology, National Cancer Centre, Singapore, Singapore\n\nSu Pin Choo\n\nMedical Oncology, University and Hospital Trust of Verona, Verona, Italy\n\nSara Cingarlini & Michele Milella\n\nDepartment of Pediatrics, University Hospital Schleswig-Holstein, Kiel, Germany\n\nAlexander Claviez\n\nHepatobiliary/Pancreatic Surgical Oncology Program, University Health Network, Toronto, ON, Canada\n\nSean Cleary, Ashton A. Connor & Steven Gallinger\n\nSchool of Biological Sciences, University of Auckland, Auckland, New Zealand\n\nNicole Cloonan\n\nDepartment of Surgery, University of Melbourne, Parkville, VIC, Australia\n\nMarek Cmero\n\nThe Murdoch Children’s Research Institute, Royal Children’s Hospital, Parkville, VIC, Australia\n\nMarek Cmero\n\nWalter and Eliza Hall Institute, Parkville, VIC, Australia\n\nMarek Cmero\n\nVancouver Prostate Centre, Vancouver, Canada\n\nColin C. Collins, Nilgun Donmez, Faraz Hach, Salem Malikic, S. Cenk Sahinalp, Iman Sarrafi & Raunak Shrestha\n\nLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada\n\nAshton A. Connor, Steven Gallinger, Robert C. Grant, Treasa A. McPherson & Iris Selander\n\nUniversity of East Anglia, Norwich, UK\n\nColin S. Cooper\n\nNorfolk and Norwich University Hospital NHS Trust, Norwich, UK\n\nMatthew G. Cordes, Catrina C. Fronick & Tom Roques\n\nVictorian Institute of Forensic Medicine, Southbank, VIC, Australia\n\nStephen M. Cordner\n\nDepartment of Biomedical Informatics, Harvard Medical School, Boston, MA, USA\n\nIsidro Cortés-Ciriano, Jake June-Koo Lee & Peter J. Park\n\nDepartment of Chemistry, Centre for Molecular Science Informatics, University of Cambridge, Cambridge, UK\n\nIsidro Cortés-Ciriano\n\nLudwig Center at Harvard Medical School, Boston, MA, USA\n\nIsidro Cortés-Ciriano, Jake June-Koo Lee & Peter J. Park\n\nHuman Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA\n\nKyle Covington, HarshaVardhan Doddapaneni, Richard A. Gibbs, Jianhong Hu, Joy C. Jayaseelan, Viktoriya Korchina, Lora Lewis, Donna M. Muzny, Linghua Wang, David A. Wheeler & Liu Xi\n\nPeter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia\n\nPrue A. Cowin, Anne Hamilton, Gisela Mir Arnau & Ravikiran Vedururu\n\nPhysics Division, Optimization and Systems Biology Lab, Massachusetts General Hospital, Boston, MA, USA\n\nDavid Craft\n\nDepartment of Medicine, Baylor College of Medicine, Houston, TX, USA\n\nChad J. Creighton\n\nUniversity of Cologne, Cologne, Germany\n\nYupeng Cun, Martin Peifer & Tsun-Po Yang\n\nInternational Genomics Consortium, Phoenix, AZ, USA\n\nErin Curley & Troy Shelton\n\nGenomics Research Program, Ontario Institute for Cancer Research, Toronto, ON, Canada\n\nKarolina Czajka, Jenna Eagles, Thomas J. Hudson, Jeremy Johns, Faridah Mbabaali, John D. McPherson, Jessica K. Miller, Danielle Pasternack, Michelle Sam & Lee E. Timms\n\nBarking Havering and Redbridge University Hospitals NHS Trust, Romford, UK\n\nBogdan Czerniak, Adel El-Naggar & David Khoo\n\nChildren’s Hospital at Westmead, University of Sydney, Sydney, NSW, Australia\n\nRebecca A. Dagg\n\nDepartment of Medicine, Section of Endocrinology, University and Hospital Trust of Verona, Verona, Italy\n\nMaria Vittoria Davi\n\nComputational Biology Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA\n\nNatalie R. Davidson, Andre Kahles, Kjong-Van Lehmann, Alessandro Pastore, Gunnar Rätsch, Chris Sander, Yasin Senbabaoglu & Nicholas D. Socci\n\nDepartment of Biology, ETH Zurich, Zürich, Switzerland\n\nNatalie R. Davidson, Andre Kahles, Kjong-Van Lehmann, Gunnar Rätsch & Stefan G. Stark\n\nDepartment of Computer Science, ETH Zurich, Zurich, Switzerland\n\nNatalie R. Davidson, Andre Kahles, Kjong-Van Lehmann & Gunnar Rätsch\n\nSIB Swiss Institute of Bioinformatics, Lausanne, Switzerland\n\nNatalie R. Davidson, Andre Kahles, Kjong-Van Lehmann, Gunnar Rätsch & Stefan G. Stark\n\nWeill Cornell Medical College, New York, NY, USA\n\nNatalie R. Davidson, Bishoy M. Faltas & Gunnar Rätsch\n\nAcademic Department of Medical Genetics, University of Cambridge, Addenbrooke’s Hospital, Cambridge, UK\n\nHelen Davies & Serena Nik-Zainal\n\nMRC Cancer Unit, University of Cambridge, Cambridge, UK\n\nHelen Davies, Rebecca C. Fitzgerald, Nicola Grehan, Serena Nik-Zainal & Maria O’Donovan\n\nDepartments of Pediatrics and Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA\n\nIan J. Davis\n\nSeven Bridges Genomics, Charlestown, MA, USA\n\nBrandi N. Davis-Dusenbery, Sinisa Ivkovic, Milena Kovacevic, Ana Mijalkovic Lazic, Sanja Mijalkovic, Mia Nastic, Petar Radovic & Nebojsa Tijanic\n\nAnnai Systems, Inc, Carlsbad, CA, USA\n\nFrancisco M. De La Vega, Tal Shmaya & Dai-Ying Wu\n\nDepartment of Pathology, General Hospital of Treviso, Department of Medicine, University of Padua, Treviso, Italy\n\nAngelo P. Dei Tos\n\nDepartment of Computational Biology, University of Lausanne, Lausanne, Switzerland\n\nOlivier Delaneau\n\nDepartment of Genetic Medicine and Development, University of Geneva Medical School, Geneva, CH, Switzerland\n\nOlivier Delaneau\n\nSwiss Institute of Bioinformatics, University of Geneva, Geneva, CH, Switzerland\n\nOlivier Delaneau\n\nThe Francis Crick Institute, London, UK\n\nJonas Demeulemeester, Stefan C. Dentro, Matthew W. Fittall, Kerstin Haase, Clemency Jolly, Maxime Tarabichi & Peter Van Loo\n\nUniversity of Leuven, Leuven, Belgium\n\nJonas Demeulemeester & Peter Van Loo\n\nInstitute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany\n\nGerman M. Demidov, Francesc Muyas & Stephan Ossowski\n\nComputational and Systems Biology, Genome Institute of Singapore, Singapore, Singapore\n\nDeniz Demircioğlu & Jonathan Göke\n\nSchool of Computing, National University of Singapore, Singapore, Singapore\n\nDeniz Demircioğlu\n\nBig Data Institute, Li Ka Shing Centre, University of Oxford, Oxford, UK\n\nStefan C. Dentro & David C. Wedge\n\nBiomedical Data Science Laboratory, Francis Crick Institute, London, UK\n\nNikita Desai\n\nBioinformatics Group, Department of Computer Science, University College London, London, UK\n\nNikita Desai\n\nThe Edward S. Rogers Sr. Department of Electrical and Computer Engineering, University of Toronto, Toronto, ON, Canada\n\nAmit G. Deshwar\n\nBreast Cancer Translational Research Laboratory JC Heuson, Institut Jules Bordet, Brussels, Belgium\n\nChristine Desmedt\n\nDepartment of Oncology, Laboratory for Translational Breast Cancer Research, KU Leuven, Leuven, Belgium\n\nChristine Desmedt\n\nInstitute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain\n\nJordi Deu-Pons, Joan Frigola, Abel Gonzalez-Perez, Ferran Muiños, Loris Mularoni, Oriol Pich, Iker Reyes-Salazar, Carlota Rubio-Perez, Radhakrishnan Sabarinathan & David Tamborero\n\nResearch Program on Biomedical Informatics, Universitat Pompeu Fabra, Barcelona, Spain\n\nJordi Deu-Pons, Abel Gonzalez-Perez, Ferran Muiños, Loris Mularoni, Oriol Pich, Carlota Rubio-Perez, Radhakrishnan Sabarinathan & David Tamborero\n\nDivision of Medical Oncology, Princess Margaret Cancer Centre, Toronto, ON, Canada\n\nNeesha C. Dhani, David Hedley & Malcolm J. Moore\n\nDepartment of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA\n\nPriyanka Dhingra, Ekta Khurana, Eric Minwei Liu & Alexander Martinez-Fundichely\n\nInstitute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA\n\nPriyanka Dhingra, Ekta Khurana, Eric Minwei Liu & Alexander Martinez-Fundichely\n\nDepartment of Pathology, UPMC Shadyside, Pittsburgh, PA, USA\n\nRajiv Dhir\n\nIndependent Consultant, Wellesley, USA\n\nAnthony DiBiase\n\nDepartment of Cell and Molecular Biology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden\n\nKlev Diamanti, Jan Komorowski & Husen M. Umer\n\nDepartment of Medicine and Department of Genetics, Washington University School of Medicine, St. Louis, St. Louis, MO, USA\n\nLi Ding, Robert S. Fulton, Michael D. McLellan, Michael C. Wendl & Venkata D. Yellapantula\n\nHefei University of Technology, Anhui, China\n\nShuai Ding & Shanlin Yang\n\nTranslational Cancer Research Unit, GZA Hospitals St.-Augustinus, Center for Oncological Research, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium\n\nLuc Dirix, Steven Van Laere, Gert G. Van den Eynden & Peter Vermeulen\n\nSimon Fraser University, Burnaby, BC, Canada\n\nNilgun Donmez, Ermin Hodzic, Salem Malikic, S. Cenk Sahinalp & Iman Sarrafi\n\nUniversity of Pennsylvania, Philadelphia, PA, USA\n\nRonny Drapkin\n\nFaculty of Science and Technology, University of Vic—Central University of Catalonia (UVic-UCC), Vic, Spain\n\nAna Dueso-Barroso\n\nThe Wellcome Trust, London, UK\n\nMichael Dunn\n\nThe Hospital for Sick Children, Toronto, ON, Canada\n\nLewis Jonathan Dursi\n\nDepartment of Pathology, Queen Elizabeth University Hospital, Glasgow, UK\n\nFraser R. Duthie\n\nDepartment of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia\n\nKen Dutton-Regester, Nicholas K. Hayward, Oliver Holmes, Peter A. Johansson, Stephen H. Kazakoff, Conrad R. Leonard, Felicity Newell, Katia Nones, Ann-Marie Patch, John V. Pearson, Antonia L. Pritchard, Michael C. Quinn, Paresh Vyas, Nicola Waddell, Scott Wood & Qinying Xu\n\nDepartment of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK\n\nDouglas F. Easton\n\nDepartment of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK\n\nDouglas F. Easton\n\nProstate Cancer Canada, Toronto, ON, Canada\n\nStuart Edmonds\n\nUniversity of Cambridge, Cambridge, UK\n\nPaul A. Edwards, Anthony R. Green, Andy G. Lynch, Florian Markowetz & Thomas J. Mitchell\n\nDepartment of Laboratory Medicine, Translational Cancer Research, Lund University Cancer Center at Medicon Village, Lund University, Lund, Sweden\n\nAnna Ehinger\n\nHeidelberg University, Heidelberg, Germany\n\nJuergen Eils, Roland Eils & Daniel Hübschmann\n\nNew BIH Digital Health Center, Berlin Institute of Health (BIH) and Charité - Universitätsmedizin Berlin, Berlin, Germany\n\nJuergen Eils, Roland Eils & Chris Lawerenz\n\nCIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain\n\nGeorgia Escaramis\n\nResearch Group on Statistics, Econometrics and Health (GRECS), UdG, Barcelona, Spain\n\nGeorgia Escaramis\n\nQuantitative Genomics Laboratories (qGenomics), Barcelona, Spain\n\nXavier Estivill\n\nIcelandic Cancer Registry, Icelandic Cancer Society, Reykjavik, Iceland\n\nJorunn E. Eyfjord, Holmfridur Hilmarsdottir & Jon G. Jonasson\n\nState Key Laboratory of Cancer Biology, and Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Shaanxi, China\n\nDaiming Fan & Yongzhan Nie\n\nDepartment of Medicine (DIMED), Surgical Pathology Unit, University of Padua, Padua, Italy\n\nMatteo Fassan\n\nRigshospitalet, Copenhagen, Denmark\n\nFrancesco Favero\n\nCenter for Cancer Genomics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA\n\nMartin L. Ferguson\n\nDepartment of Biochemistry and Molecular Medicine, University of Montreal, Montreal, QC, Canada\n\nVincent Ferretti\n\nAustralian Institute of Tropical Health and Medicine, James Cook University, Douglas, QLD, Australia\n\nMatthew A. Field\n\nDepartment of Neuro-Oncology, Istituto Neurologico Besta, Milano, Italy\n\nGaetano Finocchiaro\n\nBioplatforms Australia, North Ryde, NSW, Australia\n\nAnna Fitzgerald & Catherine A. Shang\n\nDepartment of Pathology (Research), University College London Cancer Institute, London, UK\n\nAdrienne M. Flanagan\n\nDepartment of Surgical Oncology, Princess Margaret Cancer Centre, Toronto, ON, Canada\n\nNeil E. Fleshner\n\nDepartment of Medical Oncology, Josephine Nefkens Institute and Cancer Genomics Centre, Erasmus Medical Center, Rotterdam, CN, The Netherlands\n\nJohn A. Foekens, John W. M. Martens, F. Germán Rodríguez-González, Anieta M. Sieuwerts & Marcel Smid\n\nThe University of Queensland Thoracic Research Centre, The Prince Charles Hospital, Brisbane, QLD, Australia\n\nKwun M. Fong\n\nCIBIO/InBIO - Research Center in Biodiversity and Genetic Resources, Universidade do Porto, Vairão, Portugal\n\nNuno A. Fonseca\n\nHCA Laboratories, London, UK\n\nChristopher S. Foster\n\nUniversity of Liverpool, Liverpool, UK\n\nChristopher S. Foster\n\nThe Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel\n\nMilana Frenkel-Morgenstern\n\nDepartment of Neurosurgery, University of Florida, Gainesville, FL, USA\n\nWilliam Friedman\n\nDepartment of Pathology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan\n\nMasashi Fukayama & Tetsuo Ushiku\n\nUniversity of Milano Bicocca, Monza, Italy\n\nCarlo Gambacorti-Passerini\n\nBGI-Shenzhen, Shenzhen, China\n\nShengjie Gao, Yong Hou, Chang Li, Lin Li, Siliang Li, Xiaobo Li, Xinyue Li, Dongbing Liu, Xingmin Liu, Qiang Pan-Hammarström, Hong Su, Jian Wang, Kui Wu, Heng Xiong, Huanming Yang, Chen Ye, Xiuqing Zhang, Yong Zhou & Shida Zhu\n\nDepartment of Pathology, Oslo University Hospital Ulleval, Oslo, Norway\n\nØystein Garred\n\nCenter for Biomedical Informatics, Harvard Medical School, Boston, MA, USA\n\nNils Gehlenborg\n\nDepartment Biochemistry and Molecular Biomedicine, University of Barcelona, Barcelona, Spain\n\nJosep L. L. Gelpi\n\nOffice of Cancer Genomics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA\n\nDaniela S. Gerhard\n\nCancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany\n\nClarissa Gerhauser, Christoph Plass & Dieter Weichenhan\n\nDepartment of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA\n\nJeffrey E. Gershenwald\n\nDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA\n\nJeffrey E. Gershenwald\n\nDepartment of Computer Science, Yale University, New Haven, CT, USA\n\nMark Gerstein & Fabio C. P. Navarro\n\nDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, USA\n\nMark Gerstein, Sushant Kumar, Lucas Lochovsky, Shaoke Lou, Patrick D. McGillivray, Fabio C. P. Navarro, Leonidas Salichos & Jonathan Warrell\n\nProgram in Computational Biology and Bioinformatics, Yale University, New Haven, CT, USA\n\nMark Gerstein, Arif O. Harmanci, Sushant Kumar, Donghoon Lee, Shantao Li, Xiaotong Li, Lucas Lochovsky, Shaoke Lou, William Meyerson, Leonidas Salichos, Jonathan Warrell, Jing Zhang & Yan Zhang\n\nCenter for Cancer Research, Massachusetts General Hospital, Boston, MA, USA\n\nGad Getz & Paz Polak\n\nDepartment of Pathology, Massachusetts General Hospital, Boston, MA, USA\n\nGad Getz\n\nDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA\n\nRonald Ghossein, Dilip D. Giri, Christine A. Iacobuzio-Donahue, Jorge Reis-Filho & Victor Reuter\n\nDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA\n\nNasra H. Giama, Catherine D. Moser & Lewis R. Roberts\n\nUniversity of Sydney, Sydney, NSW, Australia\n\nAnthony J. Gill & James G. Kench\n\nUniversity of Oxford, Oxford, UK\n\nPelvender Gill, Freddie C. Hamdy, Katalin Karaszi, Adam Lambert, Luke Marsden, Clare Verrill & Paresh Vyas\n\nDepartment of Surgery, Academic Urology Group, University of Cambridge, Cambridge, UK\n\nVincent J. Gnanapragasam\n\nDepartment of Medicine II, University of Würzburg, Wuerzburg, Germany\n\nMaria Elisabeth Goebler\n\nSylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA\n\nCarmen Gomez\n\nInstitut Hospital del Mar d’Investigacions Mèdiques (IMIM), Barcelona, Spain\n\nAbel Gonzalez-Perez\n\nGenome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences (NIEHS), Durham, NC, USA\n\nDmitry A. Gordenin & Natalie Saini\n\nSt. Thomas’s Hospital, London, UK\n\nJames Gossage\n\nOsaka International Cancer Center, Osaka, Japan\n\nKunihito Gotoh\n\nDepartment of Pathology, Skåne University Hospital, Lund University, Lund, Sweden\n\nDorthe Grabau\n\nDepartment of Medical Oncology, Beatson West of Scotland Cancer Centre, Glasgow, UK\n\nJanet S. Graham\n\nNational Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA\n\nEric Green, Carolyn M. Hutter & Heidi J. Sofia\n\nCentre for Cancer Research, Victorian Comprehensive Cancer Centre, University of Melbourne, Melbourne, VIC, Australia\n\nSean M. Grimmond\n\nDepartment of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA\n\nRobert L. Grossman\n\nGerman Center for Infection Research (DZIF), Partner Site Hamburg-Borstel-Lübeck-Riems, Hamburg, Germany\n\nAdam Grundhoff\n\nBioinformatics Research Centre (BiRC), Aarhus University, Aarhus, Denmark\n\nQianyun Guo, Asger Hobolth & Jakob Skou Pedersen\n\nDepartment of Biotechnology, Ministry of Science and Technology, Government of India, New Delhi, Delhi, India\n\nShailja Gupta & K. VijayRaghavan\n\nNational Cancer Centre Singapore, Singapore, Singapore\n\nJonathan Göke\n\nBrandeis University, Waltham, MA, USA\n\nJames E. Haber\n\nDepartment of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada\n\nFaraz Hach\n\nDepartment of Internal Medicine, Stanford University, Stanford, CA, USA\n\nMark P. Hamilton\n\nThe University of Texas Health Science Center at Houston, Houston, TX, USA\n\nLeng Han, Yang Yang & Xuanping Zhang\n\nImperial College NHS Trust, Imperial College, London, INY, UK\n\nGeorge B. Hanna\n\nSenckenberg Institute of Pathology, University of Frankfurt Medical School, Frankfurt, Germany\n\nMartin Hansmann\n\nDepartment of Medicine, Division of Biomedical Informatics, UC San Diego School of Medicine, San Diego, CA, USA\n\nOlivier Harismendy\n\nCenter for Precision Health, School of Biomedical Informatics, The University of Texas Health Science Center, Houston, TX, USA\n\nArif O. Harmanci\n\nOxford Nanopore Technologies, New York, NY, USA\n\nEoghan Harrington & Sissel Juul\n\nInstitute of Medical Science, University of Tokyo, Tokyo, Japan\n\nTakanori Hasegawa, Shuto Hayashi, Seiya Imoto, Mitsuhiro Komura, Satoru Miyano, Naoki Miyoshi, Kazuhiro Ohi, Eigo Shimizu, Yuichi Shiraishi, Hiroko Tanaka & Rui Yamaguchi\n\nHoward Hughes Medical Institute, University of California Santa Cruz, Santa Cruz, CA, USA\n\nDavid Haussler\n\nWakayama Medical University, Wakayama, Japan\n\nShinya Hayami, Masaki Ueno & Hiroki Yamaue\n\nDepartment of Internal Medicine, Division of Medical Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA\n\nD. Neil Hayes\n\nUniversity of Tennessee Health Science Center for Cancer Research, Memphis, TN, USA\n\nD. Neil Hayes\n\nDepartment of Histopathology, Salford Royal NHS Foundation Trust, Salford, UK\n\nStephen J. Hayes\n\nFaculty of Biology, Medicine and Health, University of Manchester, Manchester, UK\n\nStephen J. Hayes\n\nBIOPIC, ICG and College of Life Sciences, Peking University, Beijing, China\n\nYao He & Zemin Zhang\n\nPeking-Tsinghua Center for Life Sciences, Peking University, Beijing, China\n\nYao He & Zemin Zhang\n\nChildren’s Hospital of Philadelphia, Philadelphia, PA, USA\n\nAllison P. Heath\n\nDepartment of Bioinformatics and Computational Biology and Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA\n\nApurva M. Hegde, Yiling Lu & John N. Weinstein\n\nKarolinska Institute, Stockholm, Sweden\n\nEva Hellstrom-Lindberg & Jesper Lagergren\n\nThe Donnelly Centre, University of Toronto, Toronto, ON, Canada\n\nMohamed Helmy & Jeffrey A. Wintersinger\n\nDepartment of Medical Genetics, College of Medicine, Hallym University, Chuncheon, South Korea\n\nSeong Gu Heo, Eun Pyo Hong & Ji Wan Park\n\nDepartment of Experimental and Health Sciences, Institute of Evolutionary Biology (UPF-CSIC), Universitat Pompeu Fabra, Barcelona, Spain\n\nJosé María Heredia-Genestar, Tomas Marques-Bonet & Arcadi Navarro\n\nHealth Data Science Unit, University Clinics, Heidelberg, Germany\n\nCarl Herrmann\n\nMassachusetts General Hospital Center for Cancer Research, Charlestown, MA, USA\n\nJulian M. Hess & Yosef E. Maruvka\n\nHokkaido University, Sapporo, Japan\n\nSatoshi Hirano & Toru Nakamura\n\nDepartment of Pathology and Clinical Laboratory, National Cancer Center Hospital, Tokyo, Japan\n\nNobuyoshi Hiraoka\n\nDepartment of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA\n\nKatherine A. Hoadley & Tara J. Skelly\n\nComputational Biology, Leibniz Institute on Aging - Fritz Lipmann Institute (FLI), Jena, Germany\n\nSteve Hoffmann\n\nUniversity of Melbourne Centre for Cancer Research, Melbourne, VIC, Australia\n\nOliver Hofmann\n\nUniversity of Nebraska Medical Center, Omaha, NE, USA\n\nMichael A. Hollingsworth & Sarah P. Thayer\n\nSyntekabio Inc, Daejeon, South Korea\n\nJongwhi H. Hong\n\nDepartment of Pathology, Academic Medical Center, Amsterdam, AZ, The Netherlands\n\nGerrit K. Hooijer\n\nChina National GeneBank-Shenzhen, Shenzhen, China\n\nYong Hou, Chang Li, Siliang Li, Xiaobo Li, Dongbing Liu, Xingmin Liu, Henk G. Stunnenberg, Hong Su, Kui Wu, Heng Xiong, Chen Ye & Shida Zhu\n\nDivision of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany\n\nVolker Hovestadt, Murat Iskar, Peter Lichter, Bernhard Radlwimmer & Marc Zapatka\n\nDivision of Life Science and Applied Genomics Center, Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China\n\nTaobo Hu, Yogesh Kumar, Eric Z. Ma, Zhenggang Wu & Hong Xue\n\nIcahn School of Medicine at Mount Sinai, New York, NY, USA\n\nKuan-lin Huang\n\nGeneplus-Shenzhen, Shenzhen, China\n\nYi Huang\n\nSchool of Computer Science and Technology, Xi’an Jiaotong University, Xi’an, China\n\nYi Huang, Jiayin Wang, Xiao Xiao & Xuanping Zhang\n\nAbbVie, North Chicago, IL, USA\n\nThomas J. Hudson\n\nInstitute of Pathology, Charité – University Medicine Berlin, Berlin, Germany\n\nMichael Hummel & Dido Lenze\n\nCentre for Translational and Applied Genomics, British Columbia Cancer Agency, Vancouver, BC, Canada\n\nDavid Huntsman\n\nEdinburgh Royal Infirmary, Edinburgh, UK\n\nTed R. Hupp\n\nBerlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine, Berlin, Germany\n\nMatthew R. Huska, Julia Markowski & Roland F. Schwarz\n\nDepartment of Pediatric Immunology, Hematology and Oncology, University Hospital, Heidelberg, Germany\n\nDaniel Hübschmann\n\nGerman Cancer Research Center (DKFZ), Heidelberg, Germany\n\nDaniel Hübschmann, Christof von Kalle & Roland F. Schwarz\n\nHeidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), Heidelberg, Germany\n\nDaniel Hübschmann\n\nInstitute for Computational Biomedicine, Weill Cornell Medical College, New York, NY, USA\n\nMarcin Imielinski\n\nNew York Genome Center, New York, NY, USA\n\nMarcin Imielinski & Xiaotong Yao\n\nDepartment of Urology, James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA\n\nWilliam B. Isaacs\n\nDepartment of Preventive Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan\n\nShumpei Ishikawa, Hiroto Katoh & Daisuke Komura\n\nDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA\n\nMichael Ittmann\n\nDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA\n\nMichael Ittmann\n\nMichael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA\n\nMichael Ittmann\n\nTechnical University of Denmark, Lyngby, Denmark\n\nJose M. G. Izarzugaza\n\nDepartment of Pathology, College of Medicine, Hanyang University, Seoul, South Korea\n\nJocelyne Jacquemier, Hyung-Yong Kim & Gu Kong\n\nAcademic Unit of Surgery, School of Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow Royal Infirmary, Glasgow, UK\n\nNigel B. Jamieson\n\nDepartment of Pathology, Asan Medical Center, College of Medicine, Ulsan University, Songpa-gu, Seoul, South Korea\n\nSe Jin Jang & Hee Jin Lee\n\nScience Writer, Garrett Park, MD, USA\n\nKarine Jegalian\n\nInternational Cancer Genome Consortium (ICGC)/ICGC Accelerating Research in Genomic Oncology (ARGO) Secretariat, Ontario Institute for Cancer Research, Toronto, ON, Canada\n\nJennifer L. Jennings\n\nUniversity of Ljubljana, Ljubljana, Slovenia\n\nLara Jerman\n\nDepartment of Public Health Sciences, University of Chicago, Chicago, IL, USA\n\nYuan Ji\n\nResearch Institute, NorthShore University HealthSystem, Evanston, IL, USA\n\nYuan Ji\n\nDepartment for Biomedical Research, University of Bern, Bern, Switzerland\n\nRory Johnson, Andrés Lanzós & Mark A. Rubin\n\nCentre of Genomics and Policy, McGill University and Génome Québec Innovation Centre, Montreal, QC, Canada\n\nYann Joly, Bartha M. Knoppers, Mark Phillips & Adrian Thorogood\n\nCarolina Center for Genome Sciences, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA\n\nCorbin D. Jones\n\nHopp Children’s Cancer Center (KiTZ), Heidelberg, Germany\n\nDavid T. W. Jones, Marcel Kool & Stefan M. Pfister\n\nPediatric Glioma Research Group, German Cancer Research Center (DKFZ), Heidelberg, Germany\n\nDavid T. W. Jones\n\nCancer Research UK, London, UK\n\nNic Jones & David Scott\n\nIndivumed GmbH, Hamburg, Germany\n\nHartmut Juhl\n\nGenome Integration Data Center, Syntekabio, Inc, Daejeon, South Korea\n\nJongsun Jung\n\nUniversity Hospital Zurich, Zurich, Switzerland\n\nAndre Kahles, Kjong-Van Lehmann & Gunnar Rätsch\n\nClinical Bioinformatics, Swiss Institute of Bioinformatics, Geneva, Switzerland\n\nAbdullah Kahraman\n\nInstitute for Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland\n\nAbdullah Kahraman\n\nInstitute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland\n\nAbdullah Kahraman & Christian von Mering\n\nMRC Human Genetics Unit, MRC IGMM, University of Edinburgh, Edinburgh, UK\n\nVera B. Kaiser & Colin A. Semple\n\nWomen’s Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA\n\nBeth Karlan\n\nDepartment of Biology, Bioinformatics Group, Division of Molecular Biology, Faculty of Science, University of Zagreb, Zagreb, Croatia\n\nRosa Karlić\n\nDepartment for Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany\n\nDennis Karsch & Michael Kneba\n\nGenetics and Molecular Pathology, SA Pathology, Adelaide, SA, Australia\n\nKarin S. Kassahn\n\nDepartment of Gastric Surgery, National Cancer Center Hospital, Tokyo, Japan\n\nHitoshi Katai\n\nDepartment of Bioinformatics, Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan\n\nMamoru Kato, Hirofumi Rokutan & Mihoko Saito-Adachi\n\nA.A. Kharkevich Institute of Information Transmission Problems, Moscow, Russia\n\nMarat D. Kazanov\n\nOncology and Immunology, Dmitry Rogachev National Research Center of Pediatric Hematology, Moscow, Russia\n\nMarat D. Kazanov\n\nSkolkovo Institute of Science and Technology, Moscow, Russia\n\nMarat D. Kazanov\n\nDepartment of Surgery, The George Washington University, School of Medicine and Health Science, Washington, DC, USA\n\nElectron Kebebew\n\nEndocrine Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA\n\nElectron Kebebew\n\nMelanoma Institute Australia, Macquarie University, Sydney, NSW, Australia\n\nRichard F. Kefford\n\nMIT Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA, USA\n\nManolis Kellis\n\nTissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia\n\nJames G. Kench & Richard A. Scolyer\n\nCholangiocarcinoma Screening and Care Program and Liver Fluke and Cholangiocarcinoma Research Centre, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand\n\nNarong Khuntikeo\n\nControlled Department and Institution, New York, NY, USA\n\nEkta Khurana\n\nEnglander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA\n\nEkta Khurana & Alexander Martinez-Fundichely\n\nNational Cancer Center, Gyeonggi, South Korea\n\nHark Kyun Kim\n\nDepartment of Biochemistry, College of Medicine, Ewha Womans University, Seoul, South Korea\n\nHyung-Lae Kim\n\nHealth Sciences Department of Biomedical Informatics, University of California San Diego, La Jolla, CA, USA\n\nJihoon Kim\n\nResearch Core Center, National Cancer Centre Korea, Goyang-si, South Korea\n\nJong K. Kim\n\nDepartment of Health Sciences and Technology, Sungkyunkwan University School of Medicine, Seoul, South Korea\n\nYoungwook Kim\n\nSamsung Genome Institute, Seoul, South Korea\n\nYoungwook Kim\n\nBreast Oncology Program, Dana-Farber/Brigham and Women’s Cancer Center, Boston, MA, USA\n\nTari A. King\n\nDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA\n\nTari A. King & Samuel Singer\n\nDivision of Breast Surgery, Brigham and Women’s Hospital, Boston, MA, USA\n\nTari A. King\n\nIntegrative Bioinformatics Support Group, National Institute of Environmental Health Sciences (NIEHS), Durham, NC, USA\n\nLeszek J. Klimczak\n\nDepartment of Clinical Science, University of Bergen, Bergen, Norway\n\nStian Knappskog & Ola Myklebost\n\nCenter For Medical Innovation, Seoul National University Hospital, Seoul, South Korea\n\nYoungil Koh\n\nDepartment of Internal Medicine, Seoul National University Hospital, Seoul, South Korea\n\nYoungil Koh & Sung-Soo Yoon\n\nInstitute of Computer Science, Polish Academy of Sciences, Warsawa, Poland\n\nJan Komorowski\n\nFunctional and Structural Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany\n\nMarcel Kool, Andrey Korshunov, Michael Koscher, Stefan M. Pfister & Qi Wang\n\nLaboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, , National Institutes of Health, Bethesda, MD, USA\n\nRoelof Koster\n\nInstitute for Medical Informatics Statistics and Epidemiology, University of Leipzig, Leipzig, Germany\n\nMarkus Kreuz & Markus Loeffler\n\nMorgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA\n\nSavitri Krishnamurthy\n\nDepartment of Hematology and Oncology, Georg-Augusts-University of Göttingen, Göttingen, Germany\n\nDieter Kube & Lorenz H. P. Trümper\n\nInstitute of Cell Biology (Cancer Research), University of Duisburg-Essen, Essen, Germany\n\nRalf Küppers\n\nKing’s College London and Guy’s and St. Thomas’ NHS Foundation Trust, London, UK\n\nJesper Lagergren\n\nCenter for Epigenetics, Van Andel Research Institute, Grand Rapids, MI, USA\n\nPeter W. Laird\n\nThe University of Queensland Centre for Clinical Research, Royal Brisbane and Women’s Hospital, Herston, QLD, Australia\n\nSunil R. Lakhani & Peter T. Simpson\n\nDepartment of Pediatric Oncology and Hematology, University of Cologne, Cologne, Germany\n\nPablo Landgraf\n\nUniversity of Düsseldorf, Düsseldorf, Germany\n\nPablo Landgraf & Guido Reifenberger\n\nDepartment of Pathology, Institut Jules Bordet, Brussels, Belgium\n\nDenis Larsimont\n\nInstitute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden\n\nErik Larsson\n\nChildren’s Medical Research Institute, Sydney, NSW, Australia\n\nLoretta M. S. Lau & Hilda A. Pickett\n\nILSbio, LLC Biobank, Chestertown, MD, USA\n\nXuan Le\n\nDivision of Genetics and Genomics, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA\n\nEunjung Alice Lee\n\nInstitute for Bioengineering and Biopharmaceutical Research (IBBR), Hanyang University, Seoul, South Korea\n\nJeong-Yeon Lee\n\nDepartment of Statistics, University of California Santa Cruz, Santa Cruz, CA, USA\n\nJuhee Lee\n\nNational Genotyping Center, Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan\n\nMing Ta Michael Lee\n\nDepartment of Vertebrate Genomics/Otto Warburg Laboratory Gene Regulation and Systems Biology of Cancer, Max Planck Institute for Molecular Genetics, Berlin, Germany\n\nHans Lehrach, Hans-Jörg Warnatz & Marie-Laure Yaspo\n\nMcGill University and Genome Quebec Innovation Centre, Montreal, QC, Canada\n\nLouis Letourneau\n\nbiobyte solutions GmbH, Heidelberg, Germany\n\nIvica Letunic\n\nGynecologic Oncology, NYU Laura and Isaac Perlmutter Cancer Center, New York University, New York, NY, USA\n\nDouglas A. Levine\n\nDivision of Oncology, Stem Cell Biology Section, Washington University School of Medicine, St. Louis, MO, USA\n\nTim Ley\n\nDepartment of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA\n\nHan Liang\n\nHarvard University, Cambridge, MA, USA\n\nZiao Lin\n\nUrologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA\n\nW. M. Linehan\n\nUniversity of Oslo, Oslo, Norway\n\nOle Christian Lingjærde & Torill Sauer\n\nUniversity of Toronto, Toronto, ON, Canada\n\nFei-Fei Fei Liu, Quaid D. Morris, Ruian Shi, Shankar Vembu & Fan Yang\n\nPeking University, Beijing, China\n\nFenglin Liu, Fan Zhang, Liangtao Zheng & Xiuqing Zheng\n\nSchool of Life Sciences, Peking University, Beijing, China\n\nFenglin Liu\n\nLeidos Biomedical Research, Inc, McLean, VA, USA\n\nJia Liu\n\nHematology, Hospital Clinic, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain\n\nArmando Lopez-Guillermo\n\nSecond Military Medical University, Shanghai, China\n\nYong-Jie Lu & Hongwei Zhang\n\nChinese Cancer Genome Consortium, Shenzhen, China\n\nYouyong Lu\n\nDepartment of Medical Oncology, Beijing Hospital, Beijing, China\n\nYouyong Lu\n\nLaboratory of Molecular Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China\n\nYouyong Lu & Rui Xing\n\nSchool of Medicine/School of Mathematics and Statistics, University of St. Andrews, St, Andrews, Fife, UK\n\nAndy G. Lynch\n\nInstitute for Systems Biology, Seattle, WA, USA\n\nLisa Lype, Sheila M. Reynolds & Ilya Shmulevich\n\nDepartment of Biochemistry and Molecular Biology, Faculty of Medicine, University Institute of Oncology-IUOPA, Oviedo, Spain\n\nCarlos López-Otín & Xose S. Puente\n\nInstitut Bergonié, Bordeaux, France\n\nGaetan MacGrogan\n\nCancer Unit, MRC University of Cambridge, Cambridge, UK\n\nShona MacRae\n\nDepartment of Pathology and Laboratory Medicine, Center for Personalized Medicine, Children’s Hospital Los Angeles, Los Angeles, CA, USA\n\nDennis T. Maglinte\n\nJohn Curtin School of Medical Research, Canberra, ACT, Australia\n\nGraham J. Mann\n\nMVZ Department of Oncology, PraxisClinic am Johannisplatz, Leipzig, Germany\n\nLuisa Mantovani-Löffler\n\nDepartment of Information Technology, Ghent University, Ghent, Belgium\n\nKathleen Marchal & Sergio Pulido-Tamayo\n\nDepartment of Plant Biotechnology and Bioinformatics, Ghent University, Ghent, Belgium\n\nKathleen Marchal, Sergio Pulido-Tamayo & Lieven P. C. Verbeke\n\nInstitute for Genomic Medicine, Nationwide Children’s Hospital, Columbus, OH, USA\n\nElaine R. Mardis\n\nComputational Biology Program, School of Medicine, Oregon Health and Science University, Portland, OR, USA\n\nAdam A. Margolin & Adam J. Struck\n\nDepartment of Surgery, Duke University, Durham, NC, USA\n\nJeffrey Marks\n\nInstitució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain\n\nTomas Marques-Bonet, Jose I. Martin-Subero, Arcadi Navarro, David Torrents & Alfonso Valencia\n\nInstitut Català de Paleontologia Miquel Crusafont, Universitat Autònoma de Barcelona, Barcelona, Spain\n\nTomas Marques-Bonet\n\nUniversity of Glasgow, Glasgow, UK\n\nSancha Martin & Ke Yuan\n\nInstitut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain\n\nJose I. Martin-Subero\n\nDivision of Oncology, Washington University School of Medicine, St. Louis, MO, USA\n\nR. Jay Mashl\n\nDepartment of Surgery and Cancer, Imperial College, London, INY, UK\n\nErik Mayer\n\nApplications Department, Oxford Nanopore Technologies, Oxford, UK\n\nSimon Mayes & Daniel J. Turner\n\nDepartment of Obstetrics, Gynecology and Reproductive Services, University of California San Francisco, San Francisco, CA, USA\n\nKaren McCune & Karen Smith-McCune\n\nDepartment of Biochemistry and Molecular Medicine, University California at Davis, Sacramento, CA, USA\n\nJohn D. McPherson\n\nSTTARR Innovation Facility, Princess Margaret Cancer Centre, Toronto, ON, Canada\n\nAlice Meng\n\nDiscipline of Surgery, Western Sydney University, Penrith, NSW, Australia\n\nNeil D. Merrett\n\nYale School of Medicine, Yale University, New Haven, CT, USA\n\nWilliam Meyerson\n\nDepartment of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA\n\nPiotr A. Mieczkowski, Joel S. Parker, Charles M. Perou, Donghui Tan, Umadevi Veluvolu & Matthew D. Wilkerson\n\nDepartments of Neurology and Neurosurgery, Henry Ford Hospital, Detroit, MI, USA\n\nTom Mikkelsen\n\nPrecision Oncology, OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA\n\nGordon B. Mills\n\nInstitute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany\n\nSarah Minner, Guido Sauter & Ronald Simon\n\nDepartment of Health Sciences, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan\n\nShinichi Mizuno\n\nHeidelberg Academy of Sciences and Humanities, Heidelberg, Germany\n\nFruzsina Molnár-Gábor\n\nDepartment of Clinical Pathology, University of Melbourne, Melbourne, VIC, Australia\n\nCarl Morrison, Karin A. Oien, Chawalit Pairojkul, Paul M. Waring & Marc J. van de Vijver\n\nDepartment of Pathology, Roswell Park Cancer Institute, Buffalo, NY, USA\n\nCarl Morrison\n\nDepartment of Computer Science, University of Helsinki, Helsinki, Finland\n\nVille Mustonen\n\nInstitute of Biotechnology, University of Helsinki, Helsinki, Finland\n\nVille Mustonen\n\nOrganismal and Evolutionary Biology Research Programme, University of Helsinki, Helsinki, Finland\n\nVille Mustonen\n\nDepartment of Obstetrics and Gynecology, Division of Gynecologic Oncology, Washington University School of Medicine, St. Louis, MO, USA\n\nDavid Mutch\n\nPenrose St. Francis Health Services, Colorado Springs, CO, USA\n\nJerome Myers\n\nInstitute of Pathology, Ulm University and University Hospital of Ulm, Ulm, Germany\n\nPeter Möller\n\nNational Cancer Center, Tokyo, Japan\n\nHitoshi Nakagama\n\nGenome Institute of Singapore, Singapore, Singapore\n\nTannistha Nandi & Patrick Tan\n\n32Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT, USA\n\nFabio C. P. Navarro\n\nGerman Cancer Aid, Bonn, Germany\n\nGerd Nettekoven & Laura Planko\n\nProgramme in Cancer and Stem Cell Biology, Centre for Computational Biology, Duke-NUS Medical School, Singapore, Singapore\n\nAlvin Wei Tian Ng\n\nThe Chinese University of Hong Kong, Shatin, NT, Hong Kong, China\n\nAnthony Ng\n\nFourth Military Medical University, Shaanxi, China\n\nYongzhan Nie\n\nThe University of Cambridge School of Clinical Medicine, Cambridge, UK\n\nSerena Nik-Zainal\n\nSt. Jude Children’s Research Hospital, Memphis, TN, USA\n\nPaul A. Northcott\n\nUniversity Health Network, Princess Margaret Cancer Centre, Toronto, ON, Canada\n\nFaiyaz Notta & Ming Tsao\n\nCenter for Biomolecular Science and Engineering, University of California Santa Cruz, Santa Cruz, CA, USA\n\nBrian D. O’Connor\n\nDepartment of Medicine, University of Chicago, Chicago, IL, USA\n\nPeter O’Donnell\n\nDepartment of Neurology, Mayo Clinic, Rochester, MN, USA\n\nBrian Patrick O’Neill\n\nCambridge Oesophagogastric Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK\n\nJ. Robert O’Neill\n\nDepartment of Computer Science, Carleton College, Northfield, MN, USA\n\nLayla Oesper\n\nInstitute of Cancer Sciences, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, UK\n\nKarin A. Oien\n\nDepartment of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA\n\nAkinyemi I. Ojesina\n\nHudsonAlpha Institute for Biotechnology, Huntsville, AL, USA\n\nAkinyemi I. Ojesina\n\nO’Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA\n\nAkinyemi I. Ojesina\n\nDepartment of Pathology, Keio University School of Medicine, Tokyo, Japan\n\nHidenori Ojima\n\nDepartment of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan\n\nTakuji Okusaka\n\nSage Bionetworks, Seattle, WA, USA\n\nLarsson Omberg\n\nLymphoma Genomic Translational Research Laboratory, National Cancer Centre, Singapore, Singapore\n\nChoon Kiat Ong\n\nDepartment of Clinical Pathology, Robert-Bosch-Hospital, Stuttgart, Germany\n\nGerman Ott\n\nDepartment of Cell and Systems Biology, University of Toronto, Toronto, ON, Canada\n\nB. F. Francis Ouellette\n\nDepartment of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden\n\nQiang Pan-Hammarström\n\nCenter for Liver Cancer, Research Institute and Hospital, National Cancer Center, Gyeonggi, South Korea\n\nJoong-Won Park\n\nDivision of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea\n\nKeunchil Park\n\nSamsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University School of Medicine, Seoul, South Korea\n\nKeunchil Park\n\nCheonan Industry-Academic Collaboration Foundation, Sangmyung University, Cheonan, South Korea\n\nKiejung Park\n\nNYU Langone Medical Center, New York, NY, USA\n\nHarvey Pass\n\nDepartment of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA\n\nNathan A. Pennell\n\nDepartment of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA\n\nMarc D. Perry\n\nDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, USA\n\nGloria M. Petersen\n\nHelen F. Graham Cancer Center at Christiana Care Health Systems, Newark, DE, USA\n\nNicholas Petrelli\n\nHeidelberg University Hospital, Heidelberg, Germany\n\nStefan M. Pfister\n\nCSRA Incorporated, Fairfax, VA, USA\n\nTodd D. Pihl\n\nResearch Department of Pathology, University College London Cancer Institute, London, UK\n\nNischalan Pillay\n\nDepartment of Research Oncology, Guy’s Hospital, King’s Health Partners AHSC, King’s College London School of Medicine, London, UK\n\nSarah Pinder\n\nFaculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia\n\nAndreia V. Pinho\n\nUniversity Hospital of Minjoz, INSERM UMR 1098, Besançon, France\n\nXavier Pivot\n\nSpanish National Cancer Research Centre, Madrid, Spain\n\nTirso Pons\n\nCenter of Digestive Diseases and Liver Transplantation, Fundeni Clinical Institute, Bucharest, Romania\n\nIrinel Popescu\n\nCureline, Inc, South San Francisco, CA, USA\n\nOlga Potapova\n\nSt. Luke’s Cancer Centre, Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK\n\nShaun R. Preston\n\nCambridge Breast Unit, Addenbrooke’s Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge, UK\n\nElena Provenzano\n\nEast of Scotland Breast Service, Ninewells Hospital, Aberdeen, UK\n\nColin A. Purdie\n\nDepartment of Genetics, Microbiology and Statistics, University of Barcelona, IRSJD, IBUB, Barcelona, Spain\n\nRaquel Rabionet\n\nDepartment of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI, USA\n\nJanet S. Rader\n\nHematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA\n\nSuresh Ramalingam\n\nDepartment of Computer Science, Princeton University, Princeton, NJ, USA\n\nBenjamin J. Raphael & Matthew A. Reyna\n\nVanderbilt Ingram Cancer Center, Vanderbilt University, Nashville, TN, USA\n\nW. Kimryn Rathmell\n\nOhio State University College of Medicine and Arthur G. James Comprehensive Cancer Center, Columbus, OH, USA\n\nMatthew Ringel\n\nDepartment of Surgery, Yokohama City University Graduate School of Medicine, Kanagawa, Japan\n\nYasushi Rino\n\nDivision of Chromatin Networks, German Cancer Research Center (DKFZ) and BioQuant, Heidelberg, Germany\n\nKarsten Rippe\n\nResearch Computing Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA\n\nJeffrey Roach\n\nSchool of Molecular Biosciences and Center for Reproductive Biology, Washington State University, Pullman, WA, USA\n\nSteven A. Roberts\n\nFinsen Laboratory and Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark\n\nF. Germán Rodríguez-González, Nikos Sidiropoulos & Joachim Weischenfeldt\n\nDepartment of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada\n\nMichael H. A. Roehrl & Stefano Serra\n\nDepartment of Pathology, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA\n\nMichael H. A. Roehrl\n\nUniversity Hospital Giessen, Pediatric Hematology and Oncology, Giessen, Germany\n\nMarius Rohde\n\nOncologie Sénologie, ICM Institut Régional du Cancer, Montpellier, France\n\nGilles Romieu\n\nInstitute of Clinical Molecular Biology, Christian-Albrechts-University, Kiel, Germany\n\nPhilip C. Rosenstiel & Markus B. Schilhabel\n\nInstitute of Pathology, University of Wuerzburg, Wuerzburg, Germany\n\nAndreas Rosenwald\n\nDepartment of Urology, North Bristol NHS Trust, Bristol, UK\n\nEdward W. Rowe\n\nSingHealth, Duke-NUS Institute of Precision Medicine, National Heart Centre Singapore, Singapore, Singapore\n\nSteven G. Rozen, Patrick Tan & Bin Tean Teh\n\nDepartment of Computer Science, University of Toronto, Toronto, ON, Canada\n\nYulia Rubanova, Jared T. Simpson & Jeffrey A. Wintersinger\n\nBern Center for Precision Medicine, University Hospital of Bern, University of Bern, Bern, Switzerland\n\nMark A. Rubin\n\nEnglander Institute for Precision Medicine, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY, USA\n\nMark A. Rubin\n\nMeyer Cancer Center, Weill Cornell Medicine, New York, NY, USA\n\nMark A. Rubin\n\nPathology and Laboratory, Weill Cornell Medical College, New York, NY, USA\n\nMark A. Rubin\n\nVall d’Hebron Institute of Oncology: VHIO, Barcelona, Spain\n\nCarlota Rubio-Perez\n\nGeneral and Hepatobiliary-Biliary Surgery, Pancreas Institute, University and Hospital Trust of Verona, Verona, Italy\n\nAndrea Ruzzenente\n\nNational Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, India\n\nRadhakrishnan Sabarinathan\n\nIndiana University, Bloomington, IN, USA\n\nS. Cenk Sahinalp\n\nDepartment of Pathology, GZA-ZNA Hospitals, Antwerp, Belgium\n\nRoberto Salgado\n\nAnalytical Biological Services, Inc, Wilmington, DE, USA\n\nCharles Saller\n\nSydney Medical Scho"
    }
}